TWI254744B - Integrated microarray devices - Google Patents

Integrated microarray devices Download PDF

Info

Publication number
TWI254744B
TWI254744B TW91100023A TW91100023A TWI254744B TW I254744 B TWI254744 B TW I254744B TW 91100023 A TW91100023 A TW 91100023A TW 91100023 A TW91100023 A TW 91100023A TW I254744 B TWI254744 B TW I254744B
Authority
TW
Taiwan
Prior art keywords
micro
microarray
wafer
substrate
patent application
Prior art date
Application number
TW91100023A
Other languages
Chinese (zh)
Inventor
Wei Shao
Junquan Xu
Wan-Li Xing
Jing Cheng
Original Assignee
Capital Biochip Co Ltd
Univ Tsinghua
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Capital Biochip Co Ltd, Univ Tsinghua filed Critical Capital Biochip Co Ltd
Priority to TW91100023A priority Critical patent/TWI254744B/en
Application granted granted Critical
Publication of TWI254744B publication Critical patent/TWI254744B/en

Links

Abstract

This invention relates generally to the field of microarray technology. In particular, the invention provides an integrated microarray device, which device comprises a substrate comprising a plurality of distinct microlocations and a plurality of microarray chips, wherein the number of said microlocations equals to or is more than the number of said microarray chips. In preferred embodiments, the devices also comprises a temperature controller at some or all of the microlocations. The use of the integrated microarray devices for detecting interactions among various moieties in various fields, such as clinical diagnostics, drug discovery, environmental monitoring and forensic analysis, etc., are further provided.

Description

1254744 A7 B7 五、發明説明(1 技術範疇 本發明一般係關於微陣列技術範疇。特別的是,本發明 才疋供一種積體微陣列裝置,該裝置包括具有多個個別微位 置(nucrolocation)以及多個微陣列晶片的基底,其中該微 位置的數量等於或大於該微陣列晶片的數量。在較佳的具 體實例中,戎裝置還包括某些或全部微位置上的溫度控制 器。該積體微陣列裝置可用以偵測在各種領域中不同部份 <間的交互作用,例如臨床診斷,藥品研發,環境監控以 及法醫檢定分析等。 背景技藝 自從在 1990 年代(佛德(Fod〇r)等人,sdence,251:767-77 j (1991))首度現身之後,微陣列技術已經迅速地發展。 目前代表性的生物晶片(biochip )技術中,已經廣泛地將微 陣列技術應用在臨床診斷,疾病機制研發,藥品研發,環 境監控’機能基因研發等(哈希爾(Hacia)等人,Nature1254744 A7 B7 V. INSTRUCTIONS (1 Technical Field The present invention relates generally to the field of microarray technology. In particular, the present invention provides an integrated microarray device having a plurality of individual microlocations and A substrate of a plurality of microarray wafers, wherein the number of micro-locations is equal to or greater than the number of micro-array wafers. In a preferred embodiment, the germanium device further includes temperature controllers at some or all of the micro-positions. Bulk microarray devices can be used to detect interactions between different parts of various fields, such as clinical diagnostics, drug development, environmental monitoring, and forensic analysis. Background technology since the 1990s (Fod〇r ) et al., sdence, 251: 767-77 j (1991)) Microarray technology has developed rapidly since its first appearance. Currently, in the biochip technology, microarray technology has been widely used. Clinical diagnosis, disease mechanism development, drug research and development, environmental monitoring, functional gene development, etc. (Hacia et al., Nature

Genetics,Η: 441-447 (1996);以及黑勒(Heller)等人, Proc. Natl. Acad. Sci· USA,丛:2150-2155 (1997))。生物探 針,例如,寡核甞酸,DNA,RNA,肽,蛋白質,細 胞,組織,會固定於,例如玻璃’矽,尼龍膜等各種基底 的表面上。該些探針分別代表著特殊的資訊。也會將樣本 加入該反應中,其中會該加入微陣列與固定的探針產生交 互作用。樣本會以同位素,螢光劑,化學冷光劑標示以促 進積測。根據不同的標示方法,可以使用各種的偵測方 法,例如,共焦螢光掃瞄器,低冷光偵測器,同位素映像 -4- 本紙張尺度適用中國國家標準(CNS) A4規格(210 X 297公釐) 1254744 A7 _____ B7 五、發明説明(2 ) 器等。 為了達到高總流量平行分析的目的,已經開發出高密度 微陣列,有數以千計的探針固定於其上。但是在許多的例 子中’並非一定需要高密度及高成本的微陣列。此外,高 密度微陣列並非一定就可以精確地進行信號偵測,因為微 陣列上不同的探針具有本質上都具有些微的不同。舉例來 說,如果探針係DN A分子的話,其具有不同數量的鹼基 或不同的序列,兩者都會影響改變最佳雜交狀況之後的結 果 /、有在取佳的混成情況下,不匹配比率才可以降低以 便產生精確的混成信號。此外,因為每次只能偵侧一次, 所以該偵測作業對於大部份的微陣列來說相當的不方便。 發明福霞 本發明提供一種具有高效率,高精確度及低成本可以應 用於多種化學以及/或是生物樣本反應及偵測的積體微陣 列裝置。 ' 在其中一項觀點中,本發明提供一種積體微陣列裝置, 孩裝置包括具有多個個別微位置以及多個微陣列晶片的基 底’其中該微位置的數量等於或大於該微陣列晶片的數 量。在較佳的具體實例中,該裝置還包括某些或全部微位 置上的溫度控制器。 在另一項觀點中,本發明提供一種方法用以偵測在各種 目標成分之間的交互作用,該方法包括·· a)提供一種積體 微陣列裝置,該裝置包括具有多個個別微位置以及多個微 陣列晶片的基底,其中該微位置的數量等於或大於該微陣 --- - 5 本紙張尺度適用中國國家標準(CNS) A4規^^ 297公董) 1254744 五、發明説明(3 ) 列晶片的數量,以及多個目標成分係附著在該微陣列晶片 上^ b)利用步驟a)所提供之該多個目標成分接觸一測試 成分;以及〇偵測該測試成分及多個目標成分之間的交 互作用。 在一較佳的具體實例中,此處所提供的裝置包括一基 f,其上會製造反應♦。在每一反應井中會放置_微陣列 阳片。此微陣列晶片係高或低,較佳的係低密度晶片。此 外,溫度控制器係放置在上面提及的每一反應井的内部或 外部。孩些溫度控制器可以單獨控制每一反應井之溫度。 當製造此類微陣列裝置的微陣列晶片時,會根據其各自的 熔化溫度(Tm值)將探針劃分成不同的族群。熔化溫度值 相f接近的探針會固定在同一個微陣列晶片上;接著會將 该晶片放入反應井中。不同反應井的反應溫度可以利用各 自附者的溫度控制器來控制。每個井的反應溫度可以根據 固足探針的Tm值進行精確的控制以降低因不當的溫度控 制所造成的位置錯誤比率或是偵測誤差。此微陣列裝置的 尺寸符合標準96-井盤,38‘井盤或153卜井盤。也就是 說,反應井的數量及不同井之間的距離係標準化的。此種 叹计可以促使簡單,鬲效率及自動化的操作就像是利用機 器人進行樣本處理及清洗。 選式簡單說明 在圖式中’相同的參考數字表示相同的部份。 圖1所示的係範例積體微陣列裝置之俯視圖式。 圖2所示的係範例積體微陣列裝置之三維圖式。 -6 本紙張尺度適用中國國家標準(CNS) A4規格(21〇χ 297公釐) 1254744 A7 B7 五、發明説明(4 圖3所示的係溫度控制器之電子連接線圖式,其係範例 積體微陣列裝置的一部份。 圖4所示的係使用於本發明之微陣列裝置的半導體溫度 控制器之結構圖式。 主查Ji的進行楛式 為使本揭露更清楚,但並非予以限制,會將本發明的細 部說明劃分為下面的子部份。 A·定義 除非另有定義,否則此處所使用的全部技術專有名詞及 科學專有名詞與熟悉本發明所屬之技藝的人士一般所了解 的專有名詞具有相同的意義。此處所參考的所有專利,申 請案’已公告之申請案及其它公開的申請案將全部予以參 考。如果此部份所提出的定義與於此參考引用之申請案, 已公告足申請案及其它公開申請案中的定義相反或不一致 的話,則以此部份所提出的定義為準。 此處使用到,” a,,或” an ”時意指”至少一項,,或,,一項或 多項”。 ^ 當於此處使用時,”微陣列晶片”所指的係具有多個一 維,一維,或二維微結構或微型(micr〇_Scale)結構之固態 基底,於其上可以進行特定的處理,例如,物理,化學, 生物,生物物理或生物化學等處理。微結構或微型結構例 如,通道及井,會合併在,製造於或是附著在該基底以促 進該晶片上的物理,生物,生物化學,化學反應或處理。 該晶片在某一維度中可能是非常地薄,但是在其它的維度 -7- 本紙張尺度適用中國國务標準(CNS) A4規格(210X 297公爱:) 1254744 A7 B7 五、發明説明(5 ) 則具有各種形狀,舉例來說,長方形,圓形,橢圓形,或 其它的不規則形狀。該晶片主要表面的尺寸變化非常的 大,例如,從約1 mm2至約0.25 m2。較佳的係,該晶片之 尺寸從約4 mm2至約25 cm2,其特徵維度具從約1 mm至約 5 cm。該晶片表面可以是平整的’或是,不平整的。不平整 表面中的晶片包括在該表面上所製造的通道或井。 當於此處所使用時,”微位置”所指的係在内部,表面上 或附著於該基底其中放置微陣列以及/或是其它結構ϋ 置的地方。 當於此處使用時,”個別微位置”所指的係,如果須要的 話,被充分微分離的微位置,因此可以加入以及/或是移 開試劑並且可以在某個微位置中獨立地進行反應。沒有必 要讓每個微位置與所有其它的微位置”不相同”,雖然在 某些具體實例中,每個微位置可以與所有其它的微位置不 相同。 當於此處使用時’ ”微位置係在井格式中,,所指的係在微 位置處具有適當二維形狀的凹陷使得可以内建或是放入微 陣列晶片以及/或是其它結構或裝置,例如溫度控制器。 當於此處使用時,”微位置係熱絕緣的”所指的係該微位 置具有某些可以用以調整及維持某個微位置在所希望的溫 度上,不受其它微位置或任何微位置外部的地方影響。 當於此處使用時,”成分(moiety ) ”包含測試成分及目標 成分兩者。成分的非限制實例包括細胞,細胞器官,病 毒,顆粒,分子,例如,蛋白質,DNA及RNA,或其聚Genetics, Η: 441-447 (1996); and Heller et al., Proc. Natl. Acad. Sci. USA, Cong: 2150-2155 (1997)). Bioprobes, for example, oligonucleotides, DNA, RNA, peptides, proteins, cells, tissues, are immobilized on the surface of various substrates such as glass 矽, nylon membranes, and the like. These probes represent special information. Samples are also added to the reaction where the microarray is added to interact with the immobilized probe. Samples are labeled with isotopes, fluorescers, and chemical luminescent agents to facilitate integration. Various detection methods can be used according to different marking methods, for example, confocal fluorescent scanner, low luminescence detector, isotope imaging -4- This paper scale is applicable to China National Standard (CNS) A4 specification (210 X 297 PCT) 1254744 A7 _____ B7 V. Description of invention (2) Apparatus, etc. In order to achieve high total flow parallel analysis, high density microarrays have been developed with thousands of probes attached thereto. However, in many instances, a high density and high cost microarray is not necessarily required. In addition, high-density microarrays do not necessarily perform accurate signal detection because the different probes on the microarray are inherently slightly different. For example, if the probe is a DN A molecule, it has a different number of bases or a different sequence, both of which affect the result after changing the optimal hybridization state. / In the case of better mixing, there is no match. The ratio can be lowered to produce an accurate mixed signal. In addition, because only one side can be detected at a time, this detection operation is quite inconvenient for most microarrays. Invention Fu Xia The present invention provides an integrated microarray device which can be applied to various chemical and/or biological sample reactions and detections with high efficiency, high precision and low cost. In one aspect, the present invention provides an integrated microarray device comprising a substrate having a plurality of individual micro-locations and a plurality of microarray wafers, wherein the number of micro-locations is equal to or greater than that of the microarray wafer Quantity. In a preferred embodiment, the apparatus also includes some or all of the temperature controllers in the micro position. In another aspect, the present invention provides a method for detecting interaction between various target components, the method comprising: a) providing an integrated microarray device comprising a plurality of individual micro-locations And a substrate of the plurality of microarray wafers, wherein the number of the micro-positions is equal to or greater than the micro-array---- 5 the paper size is applicable to the Chinese National Standard (CNS) A4 regulation ^^ 297 dongdong) 1254744 V. Description of the invention 3) the number of column wafers, and a plurality of target components attached to the microarray wafer, b) contacting the plurality of target components provided by step a) with a test component; and detecting the test component and the plurality of The interaction between the target components. In a preferred embodiment, the apparatus provided herein includes a base f upon which a reaction ♦ is made. A _microarray positive film is placed in each reaction well. The microarray wafer is high or low, preferably a low density wafer. In addition, the temperature controller is placed inside or outside each of the reaction wells mentioned above. Child temperature controllers can individually control the temperature of each reaction well. When fabricating microarray wafers of such microarray devices, the probes are divided into different populations according to their respective melting temperatures (Tm values). Melting temperature values Probes with phase f close to each other will be attached to the same microarray wafer; the wafer will then be placed in the reaction well. The reaction temperatures of the different reaction wells can be controlled using the temperature controller of each individual. The reaction temperature of each well can be precisely controlled based on the Tm value of the fixed probe to reduce the position error ratio or detection error caused by improper temperature control. The size of this microarray device conforms to the standard 96-well plate, 38' well plate or 153 well plate. That is, the number of reaction wells and the distance between different wells are standardized. This kind of sigh can promote simple, efficient and automated operations like sample handling and cleaning with a robot. BRIEF DESCRIPTION OF THE DRAWINGS In the drawings, the same reference numerals indicate the same parts. Figure 1 is a top plan view of an exemplary integrated microarray device. Figure 3 is a three-dimensional diagram of an exemplary integrated microarray device. -6 This paper scale applies to China National Standard (CNS) A4 specification (21〇χ 297 mm) 1254744 A7 B7 V. Invention description (4 Figure 3 shows the electronic connection diagram of the temperature controller, its example A part of the integrated microarray device. Figure 4 is a structural diagram of a semiconductor temperature controller used in the microarray device of the present invention. The main method of checking Ji is to make the disclosure clearer, but not Limitations, the detailed description of the invention will be divided into the following sub-sections. A. Definitions Unless otherwise defined, all technical terms and scientific terms used herein are used in connection with those skilled in the art to which the invention pertains. The generic terms that are generally understood have the same meaning. All of the patents referred to in the application, the published applications and other published applications, are hereby incorporated by reference in its entirety. In the case of a referenced application, if the definitions in the published application and other public applications are contrary or inconsistent, the definitions set forth in this section shall prevail. “A, Or "an" means "at least one, or, or, one or more". ^ When used herein, "microarray wafer" refers to a system that has multiple one-dimensional, one-dimensional, or A solid substrate of a two-dimensional microstructure or micr〇_Scale structure on which specific processing can be performed, such as physical, chemical, biological, biophysical, or biochemical processing. Microstructures or microstructures, for example, channels And wells, which are either fabricated or attached to the substrate to promote physical, biological, biochemical, chemical reactions or processing on the wafer. The wafer may be very thin in one dimension, but in others Dimensions -7- This paper scale applies to China National Standard (CNS) A4 specification (210X 297 public love:) 1254744 A7 B7 5. Invention description (5) has various shapes, for example, rectangular, round, oval Or other irregular shape. The size of the major surface of the wafer varies very much, for example, from about 1 mm 2 to about 0.25 m 2 . Preferably, the wafer has a size of from about 4 mm 2 to about 25 cm 2 , characterized by Dimensions from about 1 Mm to about 5 cm. The surface of the wafer may be flat 'or uneven. The wafer in the uneven surface includes channels or wells made on the surface. As used herein, "micro position" The reference is made internally, on the surface or attached to the substrate where the microarray and/or other structural features are placed. As used herein, the term "individual microlocation", if required, Micro-positions that are sufficiently micro-separated so that reagents can be added and/or removed and reactions can be performed independently in a certain micro-location. It is not necessary to have each micro-location be "different" from all other micro-locations, although In some embodiments, each micro position may be different from all other micro positions. When used herein, the 'micro position' is in the well format, referring to a depression having a suitable two-dimensional shape at the micro-position that allows for the built-in or placement of microarray wafers and/or other structures or A device, such as a temperature controller. As used herein, "micro-position is thermally insulated" means that the micro-position has some that can be used to adjust and maintain a certain micro-position at a desired temperature, Affected by other micro-locations or outside of any micro-locations. As used herein, "moiety" encompasses both test components and target components. Non-limiting examples of components include cells, cell organs, viruses, particles, Molecules, for example, proteins, DNA and RNA, or their aggregation

1254744 A7 -------- B7 五、發明説明(6 ) 集物或複合物。 當於此處使用時,"植物”所指的係任何各種之光合作 用,植物界的真核多複合細胞有機體,其特徵係會產生胚 芽,包含葉綠粒,具有纖維素細胞壁並且無法移^。 當於此處使用時,"動物"所指的係動物界之多細胞有機 體’其特徵係具有移動的能力,非光合新陳代謝,對於刺 激會有反應,有限的成長以及固定的形體結構。動物之非 限制實例包括鳥類例如雞,脊椎動物例如魚及哺乳動物例 如老鼠,兔子,描,狗,豬,母牛,公牛n,馬,换 子以及其它非人類的靈長類動物。 當於此處使用時,”細菌”所指的係具有不分區圓形 D N A及約7 0 S之核糖體的小原核有機體(線性維度約為j 微米)。細菌蛋白質合成物不同於真核生物。有許多抗菌 杬生素會干擾細菌蛋白質合成物但無法對受感染主體產生 作用。 當於此處使用時,”真細菌”所指的係除了古細菌之外的 細菌之主要子部份。大部份革蘭氏陽性細菌,藍細菌,類 菌質體,腸細菌,擬單胞桿菌以及葉綠粒都是真細菌。真 細菌的細胞質膜含有酯連結脂質;在細胞壁中會有肽聚糖 (如果存在的話);但是在真細菌中並未發現到内含子。 當於此處使用時,,,古細菌,,所指的係除了真細菌之外的 細菌之主要子部份。古細菌總共有三種主要目··極端嗜鹽 菌’與產甲垸菌及硫磺有關的極端嗜熱菌。古細菌不同於 核糖體結構的真細菌,具有(在某些情況下)内含子,以及 -9- I紙張尺度適财s a家標準(CNS) M規格( x 297公董) 12547441254744 A7 -------- B7 V. INSTRUCTIONS (6) Collectives or complexes. As used herein, "plant" refers to any of a variety of photosynthesis, plant-derived eukaryotic multi-complexed cell organisms that are characterized by the production of germs, contain chloroplasts, have cellulosic cell walls and are incapable of shifting ^. When used herein, "animal" refers to the multicellular organisms of the animal kingdom's characteristics that have the ability to move, non-photosynthetic metabolism, response to stimuli, limited growth, and fixed shape Structures. Non-limiting examples of animals include birds such as chickens, vertebrates such as fish and mammals such as mice, rabbits, tracing, dogs, pigs, cows, bulls, horses, transposons, and other non-human primates. As used herein, "bacteria" refers to a small prokaryotic organism (linear dimension of approximately j microns) that does not partition circular DNA and approximately 70 S ribosomes. Bacterial protein complexes differ from eukaryotes There are many antibacterial vitamins that interfere with bacterial protein synthesis but do not affect the infected subject. When used here, the term "eubacteria" refers to The main part of bacteria other than archaea. Most Gram-positive bacteria, cyanobacteria, mycoplasma, intestinal bacteria, Bacteroides and chloroplasts are all eubacteria. The membrane contains ester-linked lipids; there are peptidoglycans in the cell wall (if present); but no introns are found in eubacteria. When used here, archaea, the system referred to In addition to the main sub-particulates of bacteria other than eubacteria, archaea has a total of three main subjects · Extreme halophilic bacteria's extremely thermophilic bacteria associated with mites and sulphur. The ancient bacterium is different from the ribosome structure. Bacteria, with (in some cases) introns, and -9-I paper scales for the standard of home (CNS) M specifications (x 297 dong) 1254744

其冗包括薄膜合成物的特性。 田於此處使用時,”病毒,,所指的係為必要寄生於生物細 胞内以生存但並無細胞特質,纟由⑽八或㈣Α及蛋白質 外層所構成。病毒的直徑範圍從約2 〇至約3 。等級! ^毒(巴爾的摩分級法)具有雙股的DN A作為其基因組; 等級π病母具有單股的DNA作為其基因組;等級丨〗〗病毒 具有雙股RN A作為其基因組;等級以病毒具有正單股 RNA作為其基因組,該基因組本身係充當mRNA ;等級v 病母具有負單股RN A作為其基因組用以當作mRNA合成之 模板;以及等級…病毒具有正單股RNA基因組,但是 DNA中間體不僅在複製中而且還會在mRN a的合成中。 大多數的病毒都會被當成係導致植物,動物及原核生物的 疾病原因。 當於此處使用時,”真菌,,所指的係生長於不規則質量中 的真核生物之分類,沒有根,莖,或葉子,並且缺乏葉綠 素或其它可行光合作用之色素。每個有機體(葉狀體)都係 單細胞至絲狀,並且具有被含有葡聚糖或幾丁質或兩者皆 具的細胞壁所圍繞的分支細胞體結構(菌絲),並且含有真 細胞核。 當於此處使用時,"細胞内成分”所指的係常駐在或位於 細胞内部之任何成分’換言之,如果有其中一個存在的 話,放置在細胞器之細胞質或母體内,附著在任何的細胞 膜上,常駐在或放置在同質内,如果有其中一個存在的 話,或常駐在或放置在細胞表面,換言之,附著在細胞質 -10-Its redundancy includes the properties of the film composition. When used in this field, "virus," refers to the need to parasitize in biological cells to survive but has no cell traits, consisting of (10) eight or (four) sputum and the outer layer of protein. The diameter of the virus ranges from about 2 〇 To about 3. Grade! ^Poly (Baltimore classification) has double-stranded DN A as its genome; grade π diseased mother has single-stranded DNA as its genome; rank 丨〗 virus has double-stranded RN A as its genome; The virus has a positive single-stranded RNA as its genome, and the genome itself acts as an mRNA; the grade v disease has a negative single-stranded RN A as its genome for use as a template for mRNA synthesis; and the grade... virus has positive single-stranded RNA Genomics, but DNA intermediates are not only in replication but also in the synthesis of mRN a. Most viruses are thought to cause disease in plants, animals and prokaryotes. When used here, "fungus, The classification refers to the classification of eukaryotes that grow in irregular mass, without roots, stems, or leaves, and lacks chlorophyll or other pigments that are viable for photosynthesis. Each organism (foliate) is unicellular to filamentous and has a branched cell structure (hyphae) surrounded by cell walls containing dextran or chitin or both, and contains true nuclei . As used herein, "intracellular component" refers to any component that is resident or located inside a cell. In other words, if one of them is present, it is placed in the cytoplasm or mother of the organelle and attached to any On the cell membrane, resident or placed in the same quality, if one of them exists, or resident or placed on the cell surface, in other words, attached to the cytoplasm -10-

1254744 A7 B7 五、發明説明(8 ) 膜或細胞壁的外表面上。 當於此處使.用時,”大分子”所指的係,沒有附著在另一 分子,可以產生特別結合至該大分子之抗體的分子。 當於此處使用時,’’小分子’’所指的係,沒有形成等質聚 集物(homo-aggregate )或沒有附著於大子或微小顆粒,無 法產生特別結合至該小分子之抗體的分子。較佳的係,該 小分子具有約或小於1〇,〇〇〇道爾頓之分子重量。更特別的 係,該小分子具有約或小於5,000道爾頓之分子重量。 當於此處使用時,’’維生素”所指的係某些生物物種中所 需要的追蹤有機物質。大部份的維生素其功能係作為特定 輔酶的構成要素。 當於此處使用時,”脂質’’所指的係不溶解於水,利用非 極性溶劑,例如三氯甲烷或乙醚,可以從細胞及組織中析 取出含油或油脂的有機物質。 當於此處使用時,"受體”所指的係具有已知配體之親合 性的分子。受體可以係自然生成的或是合成分子。受體在 本技藝中亦稱之為抗配體(anti-ligand)。當於此處使用 時,該受體及抗配體可交換使用的。受體可使用於非改變 狀態下或是與其它的種類聚集。受體可以附著在(以共價 或非共價方式)或直接或間接地經由指定的結合物質或連 接器實際接觸至一結合體。受體的實例,包括,但非限 制:抗體,細胞膜受體表面受體以及内在受體,與特定抗 原決定部位反應[例如在病毒,細胞,或其它物質上]的單 株抗體及抗血清,藥物,多核备酸,核酸,肽,輔因 -11 - 本紙張尺度適用中國國家標準(CNS) A4規格(210 X 297公釐) 1254744 A7 B7 五、發明説明(9 ) 子,凝集酸,糖,多醣,細胞,細胞膜,以及細胞器。 當於此處使用時,”抗體"包括抗體片段,例如Fab片 段’其係由輕鏈及重鏈的可變區所組成。 當於此使用時,”人源化抗體”所指的係經過修改之後包 括氨基酸等”人類”序列使得施用於人體時不會導致免疫 反應的抗體。此類抗體的製備方法已為大家所熟知。舉^ 來說,表現單株抗體的雜交瘤可以利用DNa重組技術作 修改之後以表現抗體其中之不可變區域之氨基酸組成係由 基於人體的抗體。已經設計出電腦程式以辨識此類區域。 當於此處使用時,"結構上以及/或是功能上相關的蛋白 質群組”所指的係一群在其自然狀態下的蛋白質,其係結 構上連接,位於相同的細胞位置,例如,細胞器,位於相 ㈣組織或器官中,表現以及/或是作為相同生物階段的 功能,例如,特殊細胞周期階段或發育階段,或是表現以 及/或是作為相同生物路徑的功能,例如,特殊新陳代謝 路徑,信號轉導路徑等。該,,結冑上以及/或是功能上相關 =蛋白質群組,,只須要包括至少兩個屬於相同群組之蛋白 貝。較佳的係”結構上以及/或是功能上相關的蛋白質群組 ’’包括兩個以上屬於相同群組之蛋白質,例如大部份或甚 至全部的蛋白質都屬於相同的群組。 當於此處使用時,”營養或貯藏蛋白質”所指的係被細胞 田作言養來源或此類營養之貯藏方式的蛋白質。營養戋胖 藏蛋白質之非限制實例包括麥醇溶蛋白,卵白蛋白,酪蛋 白’以及鐵蛋白。 口 L _ - 12- 本紙張尺度適用中國國豕標準(Cns) 規格(21〇χ的7公爱) 1254744 五、發明説明(1〇 當於此處使用時,,•收縮或活動蛋白 胞及有機體具有收縮,改變來 所和的係賦予細 質。收縮戋、舌重Λ疋占所、 或四處移動能力的蛋白 收、4舌動蛋白質〈非限制實例包 W 蛋白,微管蛋白及動力蛋白。 ,肌凝 當於此處使用時,”結構蛋 絲,纜線,或片層以提供生物 曰:係用以作為纖 蛋白質。处構Α物W構力I或保護生物結構的 虫白貝、、、口構蛋白貝〈非限制實例包 膠原蛋白,彈力蛋白以及黏蛋白。 、,、.“蛋白’ 當於此處使用時,”防護蛋白質 ^ ^ ,. g々係利用其它種 k免有機姐被&人或是保護它們免於遭受侵害的蛋 2蛋白質之非限制實例包括抗體,纖維素原,凝血酶 肉母桿菌毒素,白喉毒素’蛇毒液及惹麻毒蛋白。 當於此處使用時,"調節蛋白質"所指的係寶助調整如 或生理活動的蛋白質。調節蛋白質之非限制實例包括姨 素,成長荷爾蒙,促腎上腺皮質素及阻抑蛋白。 當於此處使用時,,,樣本•,所指的係包含解分析試驗所 要的分析對象的任何物質。該樣本係生物樣本,例如生 液體或生物組織。生物液體實例包括尿,血,血漿, 清,唾液,精液,糞便,痰,腦脊髓液體,淚水,黏液 羊水或類似的物質。生物組織係細胞聚集體,其通常係 形成人類,動物,植物,細菌,真菌或病毒結構的其中一 種結構物質的細胞内物質連接在一起的特殊種類,包括結 缔組織,上皮組織,肌肉組織及神經組織。生物組織實例 示包括咨^ ’腫塊’淋巴節,動脈及個別的細胞。該樣 類 '裝 胞 島 需 物1254744 A7 B7 V. INSTRUCTIONS (8) On the outer surface of the membrane or cell wall. As used herein, a term "macromolecule" refers to a molecule that is not attached to another molecule and that produces an antibody that specifically binds to the macromolecule. As used herein, a ''small molecule'' refers to a line that does not form a homo-aggregate or is not attached to a large or small particle and is unable to produce an antibody that specifically binds to the small molecule. molecule. Preferably, the small molecule has a molecular weight of about or less than 1 〇, 〇〇〇 Dalton. More particularly, the small molecule has a molecular weight of about or less than 5,000 Daltons. As used herein, ''vitamin'' refers to the tracking of organic matter required in certain biological species. Most of the vitamins function as a component of a specific coenzyme. When used here," The lipids are not dissolved in water, and an organic substance containing oil or fat can be extracted from cells and tissues by using a non-polar solvent such as chloroform or diethyl ether. As used herein, "receptor" refers to a molecule having the affinity for a known ligand. The receptor may be a naturally occurring or synthetic molecule. The receptor is also referred to in the art. Anti-ligand. When used herein, the receptor and the anti-ligand are used interchangeably. The receptor can be used in non-altered states or aggregated with other species. The receptor can be attached to (in covalent or non-covalent manner) or in direct or indirect contact with a binding substance via a specified binding substance or linker. Examples of receptors include, but are not limited to, antibodies, cell membrane receptor surface receptors, and Intrinsic receptors, monoclonal antibodies and antiserums that react with specific epitopes [eg, on viruses, cells, or other substances], drugs, multi-nuclear acid, nucleic acids, peptides, and auxiliary factors-11 - This paper scale applies to China National Standard (CNS) A4 Specification (210 X 297 mm) 1254744 A7 B7 V. Description of Invention (9) Sub, agglutination acid, sugar, polysaccharide, cell, cell membrane, and organelle. When used herein, "antibody" "including antibody fragments, examples Fragment Fab 'which is a line light chain region and variable heavy chain composed. As used herein, "humanized antibody" refers to an antibody which, after modification, includes a "human" sequence such as an amino acid such that it does not cause an immune response when administered to a human. Methods for the preparation of such antibodies are well known. For example, a hybridoma expressing a monoclonal antibody can be modified by the DNa recombination technique to express an amino acid composition of the immutable region of the antibody from a human-based antibody. Computer programs have been designed to identify such areas. As used herein, "structural and/or functionally related protein groups" refers to a group of proteins in their natural state that are structurally linked and located at the same cellular location, for example, Organelles, located in phase (4) tissues or organs, that function and/or function as the same biological stage, for example, a particular cell cycle stage or developmental stage, or function and/or function as the same biological pathway, eg, special Metabolic pathways, signal transduction pathways, etc.., on the crusting and/or functionally related = protein group, only need to include at least two protein shells belonging to the same group. The preferred system is structurally / or functionally related protein group '' includes more than two proteins belonging to the same group, for example most or all of the proteins belong to the same group. As used herein, "nutrition or storage protein" refers to a protein that is used as a source of cultivating cells or a storage mode for such nutrients. Nutritional obesity Non-limiting examples of Tibetan proteins include gliadin, ovalbumin, casein', and ferritin. Mouth L _ - 12- This paper size applies to China National Standard (Cns) specifications (21 〇χ 7 public) 1254744 V. Description of invention (1) When used here, • Shrinkage or active protein and The organism has contraction, and the system that is added to it changes the fineness. The protein that shrinks, the tongue, the weight of the tongue, or the ability to move around, the 4 tongue protein (non-limiting example package W protein, tubulin and dynein When muscle coagulation is used here, "structural egg silk, cable, or sheet to provide biopterin: used as a fibrin. to construct a sputum W constructor I or protect the biological structure of the worm shell ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,, Non-limiting examples of organic sisters being & humans or eggs 2 proteins that protect them from attack include antibodies, cellulose precursors, thrombin botulinum toxin, diphtheria toxin venom and anesthetic proteins. When used, "regulate protein & Quoting refers to the regulation of proteins such as or physiological activities. Non-limiting examples of regulatory proteins include alizarin, growth hormone, corticotropin and repressor. When used here, ,, • Refers to any substance that is required to analyze the test object. The sample is a biological sample, such as a raw liquid or biological tissue. Examples of biological fluids include urine, blood, plasma, clear, saliva, semen, feces, sputum, brain Spinal fluid, tears, mucus, amniotic fluid, or the like. Biological tissue cell aggregates, which typically form a special species of intracellular material that is linked to one of the structural elements of a human, animal, plant, bacterial, fungal, or viral structure. , including connective tissue, epithelial tissue, muscle tissue and nerve tissue. Examples of biological tissues include the 'lumral mass' lymph nodes, arteries and individual cells.

J&L 與 訂 線 _ - 13- 本紙張尺度適用中國國家標準(CNS) A4規格(210 X 297公釐) 1254744 A7 B7 五、發明説明(I ) 本亦可以是含有以活體外製備之分子的目標蛋白質。 當於此處使用時,”結構上以及/或是功能上相關的酵素 群組”所指的係一群在其自然狀態下的酵素,其係結構上 連接,位於相同的細胞位置,例如,細胞器,/ 組織或器官中,表現以及/或是作為相同生物階= 旎,例如,特殊細胞周期階段或發育階段,或是表現以及 ^或是作為相同生物路徑的功能,例如’特殊新陳代謝路 t信號轉導路徑,或是當作路徑活化或生物功能之調節 器等。該”結構上以及/或是功能上相關的酵素群組"只須 要包括至少兩個屬於相同群組之酵素。較佳的係,,結構^ 以及/或是功能上相關的酵素群組,,包括兩個以上屬於相同 群組之酵素,例如大部份或甚至全部的酵素都屬於相同的 當於此處使用時,"在组織或器官中表現特定方式"所 的係基因表現模式其中基因只會(短暫性或是組成性: 現於特定組織或器官中,但是不會表現在其它的組織或哭 當於此處使用時,”組織"所指的係整體之相同細胞及产 繞它們之細胞内物質。人體中有四種基本的組織 : 皮;2)結缔組織’包括血液,骨頭,以及軟骨;3)肌向 組織;以及4 )神經組織。 〜 當於此處使用時,”器官,,所指的係產生特定功能的身⑲ 一部份,例如呼吸,排泄或消化。 且 當於此使用時,決定不匹配的百分比"雜交嚴謹度 -14- 1254744 A7 B7 五、發明説明(12 ) (stringency of hybridization ),,如下; 1 )南嚴謹度·· 0_ 1 x SSPE,〇. i〇/。SDS,65°C ; 2)中嚴謹度:0·2 x SSPE,o.i% SDS,5 0°C (亦稱之為 中等嚴謹),以及 J)低嚴謹度:l.OxSSPE,〇.i%SDS,50°C。 應該理解的係利用交替的緩衝劑,鹽類及溫度可以達成 相等的嚴謹度。 當於此處使用時,”基因”所指的係佔據染色體特定所在 的过傳單元’其存在可以利用不同的對偶基因型之出現加 以確認。假設有分裂基因出現,基因也會包含一組需要產 生單一多肽之D N A序列(外顯子)。 當於此處使用時,”基因晶片,,所指的係固定於表面上可 用於篩選R N A樣本(在反轉錄之後)的寡核荅酸陣列因此 也是一種可以從RN A來源快速判斷哪個基因正表現在該 細胞或組織的方法。 當於此處使用時,” R N A ’’所指的係透過碌酸二酯與附 著在Γ位置的嘌呤或嘧啶基相連接存在於3,及位置的核 糖單元。 當於此處使用時,’’蛋白質’’所指的係特定序列以肽鏈連 接的氨基酸線性聚合物。當於此處使用時,,’蛋白質,,亦 包含多肽,寡肽及肽。 B.積體微陣列裝置 在其中一項觀點中,本發明提供一種積體微陣列裝置, 該裝置包括具有多個個別微位置以及多個微陣列晶片的基 -15- 本紙張尺度適用中國國家標準(CNS) A4規格(210 X 297公釐)J&L and ordering _ - 13- This paper size applies to Chinese National Standard (CNS) A4 specification (210 X 297 mm) 1254744 A7 B7 V. Description of invention (I) This may also be a molecule containing in vitro preparation. Target protein. As used herein, a "structural and/or functionally related group of enzymes" refers to a group of enzymes in their natural state that are structurally linked and located at the same cellular location, eg, cells. , / in tissue or organ, and/or as the same biological order = 旎, for example, a special cell cycle stage or developmental stage, or a function and / or as a function of the same biological pathway, such as 'special metabolic pathways t Signal transduction path, or as a regulator of path activation or biological function. The "structural and/or functionally related enzyme group" need only include at least two enzymes belonging to the same group. Preferred lines, structures ^ and/or functionally related enzyme groups, , including two or more enzymes belonging to the same group, for example, most or even all of the enzymes are the same when used here, "expressing specific ways in tissues or organs" The pattern in which the gene is only (transient or constitutive: present in a particular tissue or organ, but not in other tissues or crying when used here, "organization" refers to the same cell as the whole And the intracellular material that produces them. There are four basic tissues in the human body: skin; 2) connective tissue 'including blood, bone, and cartilage; 3) muscle-directed tissue; and 4) nerve tissue. ~ When used herein, "organ," refers to a part of the body that produces a specific function, such as breathing, excretion, or digestion. And when used, determines the percentage of mismatch "hybrid rigor -14- 1254744 A7 B7 V. Description of invention (12) (stringency of hybridization), as follows; 1) South rigorous degree · 0_ 1 x SSPE, 〇. i〇/. SDS, 65 ° C; 2) Degree: 0·2 x SSPE, oi% SDS, 50 °C (also known as medium rigor), and J) Low stringency: l.OxSSPE, 〇.i% SDS, 50 ° C. It should be understood With alternating buffers, salts and temperatures can achieve equal stringency. When used herein, the term "gene" refers to the passage of a cell that is specific to the chromosome's existence and can utilize different dual genotypes. Appears to confirm. Assuming that a split gene is present, the gene will also contain a set of DNA sequences (exons) that need to produce a single polypeptide. When used here, "gene wafer, the indicated line is fixed on the surface available Oligonucleotides for screening RNA samples (after reverse transcription) Acid array thus also a fast Analyzing RN A from sources which expresses the gene in the cell or tissue method. As used herein, "RNA" refers to a ribose unit that is attached to the 3, and position, via a oxime or pyrimidinyl group attached to the oxime position by a diacid diester. When used herein, ' 'Protein' refers to an amino acid linear polymer in which a specific sequence is linked by a peptide chain. When used herein, 'protein, also includes polypeptides, oligopeptides and peptides. B. Integral microarray device is included therein In one aspect, the present invention provides an integrated microarray device comprising a substrate having a plurality of individual micro-locations and a plurality of microarray wafers. The paper scale is applicable to the Chinese National Standard (CNS) A4 specification (210 X 297 mm)

装 玎

1254744 A7 _______ B7 五、發明説明(13 ) 底’其中該微位置的數量等於或大於該微陣列晶片的數 量° 任何適當的基底都可以使用於本積體微陣列裝置。在較 佳的具體實例中,該基底包括矽,例如,二氧化碎或氮化 矽,塑膠,玻璃,陶瓷,橡膠,聚合物或其組合。該基底 包括厭水或親水表面。此外,該基底包括多孔或無孔表 面。 該微位置可以利用任何適當的方法產生於該基底内部, 上面或附著在該基底。舉例來說,微位置可以直接製造作 為該基底的一部份。另外,也可以先製造該基底接著在該 基底内部,上面或附著該基底產生該微位置。在較佳的具 體實例中,微位置以及/或是微陣列晶片都係製造於該基 底上。 遺裝置包括任何適當數1之微位置。舉例來說,該裝置 包括(12)d®微位置,其中n係至少為1的整數。較佳的 係,η為8,3 2或1 2 8。該微位置可以平均地或不平均地 分佈在該基底中。較佳的係,微位置的數量及微位置之間 的距離付合標準微滴定盤,例如,9 6 _,3 8 4 -,或15 ^ 6 -井 盤。 該微位置可以是任何合適的格式。舉例來說,該微位置 可以在基底内部或在表面上或在基底的表面上方製造。較 佳的係,該微位置係井格式或熱絕緣平整表面格式。該裝 置包括(12)η個井,其中η係至少為1之整數。較佳的係, 該裝置包括96,384或1,536個井。該井具有任何合適的 -16- 本紙張尺度適用中國國家標準(CNS) Α4規格(210 X 297公釐) 1254744 A7 B71254744 A7 _______ B7 V. INSTRUCTION DESCRIPTION (13) Bottom 'where the number of micro-locations is equal to or greater than the number of micro-array wafers. Any suitable substrate can be used for the integrated microarray device. In a preferred embodiment, the substrate comprises tantalum, for example, cerium oxide or tantalum nitride, plastic, glass, ceramic, rubber, polymer or a combination thereof. The substrate comprises a hydrophobic or hydrophilic surface. In addition, the substrate comprises a porous or non-porous surface. The micro-location can be created inside, on or attached to the substrate by any suitable method. For example, the microlocation can be fabricated directly as part of the substrate. Alternatively, the substrate may be fabricated first and then placed inside, or attached to, the substrate to create the micro-location. In a preferred embodiment, the micro-location and/or the microarray wafer are fabricated on the substrate. The device includes any suitable number of micro locations. For example, the device includes (12)d® micro-positions, where n is an integer of at least one. Preferably, η is 8, 3 2 or 1 2 8 . The microlocations may be distributed evenly or unevenly in the substrate. Preferably, the number of micro-positions and the distance between the micro-positions are matched to a standard microtiter plate, for example, a 9 6 _, 3 8 4 -, or 15 ^ 6 - well plate. The microlocation can be in any suitable format. For example, the micro-location can be fabricated inside or on the surface or over the surface of the substrate. Preferably, the micro position is a well format or a thermally insulated flat surface format. The apparatus includes (12) n wells, wherein the η is at least an integer of one. Preferably, the device comprises 96,384 or 1,536 wells. The well has any suitable -16- paper size applicable to China National Standard (CNS) Α4 size (210 X 297 mm) 1254744 A7 B7

五、發明説明(15 含於鄰近井之侧牆之間的空氣進行熱絕緣。 在本裝置中的微位置數量必須多於或等於微陣列晶片之 數量。較佳的係,在該裝置之每一微位置都包括一微陣列 晶片。 任何適當的微陣列晶片都可以使用於本積體微陣列裝 置。舉例來說,微陣列晶片適用於核酸分析的微陣列晶 片’例如,基因晶片,以及/或是蛋白質晶片,抗體晶 片,便可以使用於本裝置中(一般參見Ausubel等人所著 之 Current Protocols in Molecular Biblogy,§22, John Wiley &5. Description of the Invention (15) The air contained between the side walls of adjacent wells is thermally insulated. The number of micro-locations in the device must be greater than or equal to the number of microarray wafers. Preferably, each device is used. A micro-location includes a microarray wafer. Any suitable microarray wafer can be used in the integrator microarray device. For example, microarray wafers are suitable for microarray wafers for nucleic acid analysis 'eg, gene wafers, and/ Or protein wafers, antibody wafers, can be used in the device (see generally Current Protocols in Molecular Biblogy by Ausubel et al., § 22, John Wiley &

Sons,Inc.(2000);以及 Schena (Ed·),Microarray Biochip technology, Eaton Publishing Company/Bio Techniques Books Division (2000))。在特定的具體實例中,可以將下面美國 專利案號中所揭露的微陣列晶片使用於本裝置中: 6,245,51 1,6,215,894,6,142,681,6,101,946,6,004,755, 5,930,117,5,928,437 及 5,716,459 ° 該微陣列晶片可以具有任何希望的密度。該微陣列晶片 可以具有相同或不同的密度。在特定的具體實例中,該微 陣列晶片具有(100)n spots/cm2的密度,其中η係至少為1之 整數。較佳的係,至少其中一個微陣列晶片具有少於或等 於400 spots/cm2的密度。然而,可以有任何數量或百分比 之微陣列晶片,例如,50%微陣列晶片,具有少於或等於 400 spots/cm2之密度。更佳的係,全部的微陣列晶片皆具 有少於或等於400 spots/cm2之密度。 在另一特定的具體實例中,至少其中一個微陣列晶片附 -18- 本紙張尺度適用中國國家標準(CNS) A4規格(210X 297公Sons, Inc. (2000); and Schena (Ed.), Microarray Biochip technology, Eaton Publishing Company/Bio Techniques Books Division (2000)). In a specific embodiment, the microarray wafer disclosed in the following U.S. Patent No. is used in the apparatus: 6,245,51 1,6,215,894, 6,142,681, 6,101,946,6,004,755, 5,930,117, 5,928,437 and 5,716,459 ° The microarray wafer can have any desired density. The microarray wafers can have the same or different densities. In a particular embodiment, the microarray wafer has a density of (100) n spots/cm2, wherein η is at least an integer of one. Preferably, at least one of the microarray wafers has a density of less than or equal to 400 spots/cm2. However, there may be any number or percentage of microarray wafers, e.g., 50% microarray wafers, having a density of less than or equal to 400 spots/cm2. More preferably, all of the microarray wafers have a density of less than or equal to 400 spots/cm2. In another specific embodiment, at least one of the microarray wafers -18- the paper scale is applicable to the Chinese National Standard (CNS) A4 specification (210X 297

Order

12547441254744

者在多個成分中。該微陣列晶片可以以面朝上或面朝下的 万向附著在多個成分。該成分可以利用任何適當的方法附 者在孩微陣列晶片i。該<分可以共冑,非共價,透過指 疋或非指足連接,可以直接地或透過連結器附著至微陣列 晶片上。該連結器對於某些處理’例如物理,化學或發 係非常的敏感。 / Λ 任何適當的成分都可以附著至該微陣列晶片上。該成分 可以係純物質或混合材料,可以係化學或生物材料,或可 以從生物來源或樣本予以合成或隔離/淨化。範例成分包 括細胞,細胞器,病毒,分子及其聚集物或複合物。 細胞之非限制實例包括動物,植物,真菌,細菌,重組 或人工培養細胞。動物,植物,真菌,細菌細胞可以取自 任何的動物’植物,真菌或細菌界之屬或亞屬。擷取自任 何纖毛蟲,細胞黏黴菌,鞭毛蟲及小孢子蟲之屬或亞屬之 細胞亦可以附著至該微陣列晶片。擷取自鳥類例如雞,脊 椎動物例如魚及哺乳動物例如老鼠,兔子,猫,狗,豬, 母牛,公牛,綿羊,馬,猴子以及其它非人類靈長類動 物,及人類之細胞可以附著至該微陣列晶片。 以動物細胞而言,擷取自特殊組織或器官之細胞可以附 至該微陣列晶片上。舉例來說,可以使用結缔,上皮,肌 肉及神經組織細胞。相同地,擷取自眼睛的輔助器官,螺 旋形器官,耳朵器官,契維茨氏(Chievitz)器官,環室器 官,柯替(Corti)器官,重要器官,琺瑯質器官,端末器 官,外部雌性生殖器官,外部雄性生殖器官,浮動器官’ -19- 本紙張尺度適用中國國家標準(CNS) A4规格(210 X 297公釐) 1254744 A7 B7 五、發明説明 羅芬尼(Ruffim)之花枝未梢器官,生殖器官,高爾基腱器 & ,味覺器官,聽覺器官,内部雌性生殖器官,内部雄性 生殖态官,插入器官,喬可森(Jac〇bs〇n)器官,神經血 液益官,神經腱器官,嗅覺器官,内耳器官,下垂器官, 羅斯米勒(Rosenmliller)器官,感官器官,嗅覺器官,螺旋 器έ ,次接合备官,穹窿下器官,多餘器官,觸覺器官, 2標斋耳,味覺器耳,觸覺器官,泌尿器官,葉片端末血 管器官,内耳器官,前庭耳蜗器,退化器官,視覺器官, 視力器官,犁鼻器,精神器官,韋柏(Webe〇器官及魯可 甘(Zuckerkandal)器官之細胞皆可以使用。較佳的係,擷 取自内部動物器官例如,腦,肺,肝,脾,骨髓,胸線^ 祆頁原霄,胰腺 心臟,淋巴,血液 膀胱’胃,腸,卵巢,子宮,直腸,神經系統,腺,内, j管,等之細胞亦可以使用。此外,擷取自任何植物, 菌例如酵母,細菌例如真細菌或古細菌,的細胞亦可以1 用。擷取自任何真核或原核生物來源例如動物,植物, 菌或細菌細胞之重組細胞亦可以使用。人體流體例如; 液,尿,唾液,骨髓,精液或其它腹水液體,以及其子 段邵份,例如,血清或血漿,亦可以使用。 可附著的細胞器包括細胞,線粒體,葉綠粒,核糖體, ER ’高爾、基器官,溶酶體,f白酶體"分泌水泡,液泡 或微粒體。可在病毒壽命循環附著的病毒,不論是完整病 毒或任何病毒性結構,例如,病毒性顆粒,可二= = = = 級I病毒’等級II病毒’等級IU病毒’等級^毒或等: -20-Among the multiple components. The microarray wafer can be attached to multiple components with a face up or face down. This component can be attached to the microarray wafer i by any suitable method. The < points can be shared, non-covalent, connected via finger or non-finger, and attached to the microarray wafer either directly or through a connector. The connector is very sensitive to certain processes such as physics, chemistry or hair. / Λ Any suitable composition can be attached to the microarray wafer. The ingredients may be pure or mixed materials, may be chemical or biological materials, or may be synthesized or isolated/purified from biological sources or samples. Exemplary components include cells, organelles, viruses, molecules and their aggregates or complexes. Non-limiting examples of cells include animals, plants, fungi, bacteria, recombinant or artificially cultured cells. Animals, plants, fungi, bacterial cells can be obtained from any animal 's genus or subgenus of the plant, fungus or bacterial community. Cells from any genus or subgenus of any ciliate, cell slime mold, flagellate and microspores can also be attached to the microarray wafer. Extracted from birds such as chickens, vertebrates such as fish and mammals such as mice, rabbits, cats, dogs, pigs, cows, bulls, sheep, horses, monkeys and other non-human primates, and human cells can be attached To the microarray wafer. In the case of animal cells, cells drawn from a particular tissue or organ can be attached to the microarray wafer. For example, connective, epithelial, myocutaneous, and neural tissue cells can be used. Similarly, from the eye's auxiliary organs, spiral organs, ear organs, Chievitz organs, ring chamber organs, Corti organs, vital organs, sputum organs, terminal organs, external female reproduction Organs, external male reproductive organs, floating organs' -19- This paper scale applies to Chinese National Standard (CNS) A4 size (210 X 297 mm) 1254744 A7 B7 V. Inventions Description Ruffim's florets , genital organs, Golgi apparatus &, taste organs, auditory organs, internal female reproductive organs, internal male reproductive organs, inserted organs, Jac〇bs〇n organs, neuro-health organs, neural crest organs , olfactory organs, inner ear organs, sagging organs, Rosenmliller organs, sensory organs, olfactory organs, auger sputum, secondary joint preparations, underarm organs, excess organs, tactile organs, 2 standard zhai, taste detector Ear, tactile organ, urinary organ, terminal vascular organ, inner ear organ, vestibular cochlear implant, degenerative organ, visual organ, visual organ, Nasal, mental organs, Weber (Webe〇 organ and Zuckerkandal organ cells can be used. Preferred lines, extracted from internal animal organs such as, brain, lung, liver, spleen, bone marrow, chest Line ^ 祆 霄 霄, pancreatic heart, lymph, blood bladder 'stomach, intestine, ovary, uterus, rectum, nervous system, gland, inner, j tube, etc. cells can also be used. In addition, from any plant, Cells such as yeast, bacteria such as eubacteria or archaea may also be used. Recombinant cells derived from any eukaryotic or prokaryotic source such as animal, plant, bacterial or bacterial cells may also be used. Human fluids such as; , urine, saliva, bone marrow, semen or other ascites fluid, and its sub-segment, such as serum or plasma, can also be used. Attachable organelles include cells, mitochondria, chloroplasts, ribosomes, ER 'high , basal organ, lysosome, f white zymocyte "secretory vesicles, vacuoles or microsomes. Viruses that can be attached to the life cycle of a virus, whether it is a whole virus or any viral structure For example, viral particles, two Class I = = = = virus' Level II virus' level IU virus' drug or the like ^ level: -20

1254744 A7 B7 五、發明説明(18 ) VI病毒中擷取出來。 可附著的細胞内成分包括常駐或位於細胞内部,換言 之,位於細胞器之細胞質或母體内;附著至任何細胞内薄 膜;常駐或位於同質内部,如果有的話;或常駐或位於細 胞表面,換言之,附著在細胞質薄膜或細胞壁之外表面, 如果有的話,的任何成分。任何所希望的細胞内成分都可 以與目標細胞隔離。舉例來說,可以將細胞器,分子或其 聚集物或複合物隔離。此類細胞器之非限制實例包括細 胞,線粒體,葉綠粒,核糖體,蛋白酶體,分泌水泡,液 泡或微顆粒,膜狀受體,抗原,酵素以及細胞質中的蛋白 質。 可附著的分子可以係無機分子例如離子,有機分子或其 複合物。可附著離子之非限制實例包括鈉,鉀,鎂,鈣, 氣,鐵,銅,鋅,巍,姑,換,鈿,訊,鎳,銘,氟, 矽,錫,硼或砷離子。可附著分子之非限制實例包括胺基 酸,肽,蛋白質,核芬酸,寡核嘗酸,核酸,維生素,單 醣類,缺氧多糖,碳水化合物,脂質或其複合物。 任何胺基酸都可以附著至微陣列晶片。舉例來說,D -及L -胺基酸可以附著。此外,任何自然發生的肽及蛋白 質之建造區塊,包括 Ala (A),Arg (R),Asn (N),Asp (D) ,Cys (C),Gin (Q),Glu (E),Gly (G),His (Η),lie (I) ,Leu (L),Lys (K),Met (M),Phe (F),Pro (P) Ser (S), Thr(T),Trp (W),Tyr (Y)及 Val (V)都可以附著。 任何蛋白質或肽都可以附著至微陣列晶片。舉例來說, -21 - 本紙張尺度適用中國國家標準(CNS) A4規格(210 X 297公釐) 1254744 A7 B7 五、發明説明(19 ) 酵素,傳輸蛋白質例如離子通道及泵,營養或儲存蛋白 質,可收縮或可移動蛋白質例如肌動蛋白及肌凝蛋白,結 構蛋白質,防護蛋白質或調整蛋白質例如抗體,荷爾蒙及 成長係數都可以附著。蛋白質或肽抗原亦可以附著。 任何的核酸,包括單-,雙及三股核酸都可以附著至微 陣列晶片。此類核酸之實例包括D N A,例如A -,B -或Z -型式D N A,以及R N A例如mRNA,tRNA及rRNA。 任何的核甞都可以附著至微陣列晶片。此類核甞之實例 包括腺嘌呤核甞,鳥嘌呤核甞,胸嘧啶核甞,胸腺嘧啶核 甞及尿嘧啶核甞。任何的核甞酸都可以附著至微陣列晶 片。此類核茹酸的實例包括A Μ P,G Μ P,C Μ P, UMP,ADP,GDP,CDP,UDP,ATP,GTP, CTP,UTP,dAMP,dGMP,dCMP,dTMP,dADP, dGDP,dCDP,dTDP,dATP,dGTP,dCTP 及 dTTP。 任何的維生素都可以附著至微陣列。舉例來說,水溶性 維生素例如硫胺酸,核黃素於驗酸,泛酸,維生素B 6, 維生素Η,葉酸,維生素B丨2及抗壞血酸都可以附著。相 同地,亦可附著脂溶性維生素例如維生素A,維生素D, 維生素E,及維生素K。 任何的單醋類,D -或L -單膽及酿糖或嗣糖,都可以附 著至微陣列晶片。單醣類之實例包括丙糖例如甘油醛,丁 糖例如赤蘚糖及蘇糖(threose ),戊糖例如核糖,樹膠酿 糖,木糖,來蘇糖(lyxose)及核酮糖,己糖例如阿洛糖 (allose),阿卓糖(altrose),葡萄糖,甘露糖,古洛糖 -22- 本紙張尺度適用中國國家標準(CNS) A4規格(210 X 297公釐) 12547441254744 A7 B7 V. INSTRUCTIONS (18) VI virus is taken out. Attachable intracellular components include resident or located inside the cell, in other words, in the cytoplasm or mother of the organelle; attached to any intracellular membrane; resident or located within the same mass, if any; or resident or located on the cell surface, in other words Any component that attaches to the outer surface of the cytoplasmic membrane or cell wall, if any. Any desired intracellular component can be isolated from the target cell. For example, organelles, molecules or aggregates or complexes thereof can be isolated. Non-limiting examples of such organelles include cells, mitochondria, chloroplasts, ribosomes, proteasomes, secretory vesicles, vacuoles or microparticles, membranous receptors, antigens, enzymes, and proteins in the cytoplasm. The attachable molecules may be inorganic molecules such as ions, organic molecules or complexes thereof. Non-limiting examples of attachable ions include sodium, potassium, magnesium, calcium, gas, iron, copper, zinc, strontium, agar, exchange, bismuth, bismuth, nickel, indium, fluorine, antimony, tin, boron or arsenic ions. Non-limiting examples of attachable molecules include amino acids, peptides, proteins, nucleofen acids, oligonucleotides, nucleic acids, vitamins, monosaccharides, hypoxia polysaccharides, carbohydrates, lipids or complexes thereof. Any amino acid can be attached to the microarray wafer. For example, D- and L-amino acids can be attached. In addition, any naturally occurring building blocks of peptides and proteins, including Ala (A), Arg (R), Asn (N), Asp (D), Cys (C), Gin (Q), Glu (E), Gly (G), His (Η), lie (I), Leu (L), Lys (K), Met (M), Phe (F), Pro (P) Ser (S), Thr (T), Trp (W), Tyr (Y) and Val (V) can all be attached. Any protein or peptide can be attached to the microarray wafer. For example, -21 - This paper scale applies to Chinese National Standard (CNS) A4 specification (210 X 297 mm) 1254744 A7 B7 V. Description of invention (19) Enzymes, transport proteins such as ion channels and pumps, nutrient or storage proteins , contractile or mobile proteins such as actin and myosin, structural proteins, protective proteins or regulatory proteins such as antibodies, hormones and growth factors can be attached. Protein or peptide antigens can also be attached. Any nucleic acid, including single-, double-, and triple-stranded nucleic acids, can be attached to the microarray wafer. Examples of such nucleic acids include D N A, such as A -, B - or Z - type D N A, and R N A such as mRNA, tRNA and rRNA. Any core can be attached to the microarray wafer. Examples of such nucleus include adenine nucleus, guanine nucleus, thymidine nucleus, thymidine nucleus and uracil nucleoside. Any nucleoside acid can be attached to the microarray wafer. Examples of such nucleotides include A Μ P, G Μ P, C Μ P, UMP, ADP, GDP, CDP, UDP, ATP, GTP, CTP, UTP, dAMP, dGMP, dCMP, dTMP, dADP, dGDP, dCDP, dTDP, dATP, dGTP, dCTP and dTTP. Any vitamin can be attached to the microarray. For example, water-soluble vitamins such as thiamine, riboflavin can be tested for acid, pantothenic acid, vitamin B 6, vitamins, folic acid, vitamin B 2 and ascorbic acid. Similarly, fat-soluble vitamins such as vitamin A, vitamin D, vitamin E, and vitamin K may be attached. Any single vinegar, D- or L-mono-billed and sugar or sucrose, can be attached to the microarray wafer. Examples of monosaccharides include triose such as glyceraldehyde, butyrate such as erythrose and threose, pentose such as ribose, gum sugar, xylose, lyxose and ribulose, hexose For example, allose, altrose, glucose, mannose, gulose-22- This paper scale applies to China National Standard (CNS) A4 specification (210 X 297 mm) 1254744

發明説明 20 ’艾杜糖(idose) ’半乳糖,塔羅㈤〇se)以及果 糖例如景天庚酮糖(Sed〇heptul〇Se )。 一任何的脂質都可以附著至微陣列晶片。月旨質之實例包括 二醯基甘油例如三硬脂精,三棕搁精及三油精,石墙,磷 酸:油例如磷脂醯乙醇胺,磷脂醯膽鹼,磷脂醯絲胺酸, 醯肌醇及心磷脂,鞘脂例如鞘磷脂,腦荅脂及神經茚 甘月曰,固醇例如膽固醇及豆固醇及固醇脂肪酸酯。脂肪酸 Y以係飽和脂肪酸例如月桂酸,莖蔻酸,十六酸,硬脂 酸,化生酸及廿四酸,或不飽和脂肪酸例如粽搁油酸,油 故’亞麻油酸,花生四晞酸。 在特疋的具體實例中,至少會有兩個微陣列晶片附著至 夕個成岛上。然而,可以有任何數量或百分比之微陣列晶 片,例如,50%微陣列晶片,附著至多個成分。較佳的 係,每個微陣列晶片皆附著至多個成分。該微陣列晶片可 以附著至相同型式或不同型式之成分上。 在另一特定具體實例中,至少有其中一個微位置包括一 溫度控制器。然而,可以有任何數量或百分比之微位置, 例如,50%微位置,包括溫度控制器。較佳的係,每個微 位置都包括一溫度控制器。更佳的係,每個微位置都包括 一微陣列晶片及一個溫度控制器。部份的溫度控制器,例 如50%的溫度控制器,可以個別地控制。較佳的係,每個 溫度控制器都可以個別地控制。 任何合適的溫度控制器都可以使用於本裝置中。舉例來 說’可以使用電阻式加熱器,雙向半導體溫度控制器,陶 L__-23- 本紙張尺度適用中國國家標準(CNS) A4規格(210 X 297公釐) 1254744 A7 ---- B7 五、發明説明(21 ) 瓷加熱器或紅外線加熱器。 本裝置中的基底可以係單一的單元。另外,該基底可以 係組合式的單元,其可以拆解成至少兩個部份。 C.偵測方法 在另一項觀點中,本發明提供一種方法用以偵測在測試 成分及各種目標成分之間的交互作用,該方法包括:&)提 供一種積體微陣列裝置,該裝置包括具有多個個別微位置 以及多個微陣列晶片的基底,其中該微位置的數量等於或 大於茲微陣列晶片的數量,以及多個目標成分係附著在該 微陣列晶片上;b)利用步驟a)所提供之該多個目標成分 接觸一測試成分;以及c )偵測該測試成分及多個目標成分 之間的交互作用。本方法可以用於任何適合的範疇包括預 後(prognosis),診斷,藥物篩選,環境監視等。 任何適當的積體微陣列裝置,包括在上面B部份所討論 的裝置,都可以使用於本方法中。在特定的具體實例中, 該積體微陣列裝置包括含有多個個別微位置的基底而每個 微位置都包括一微陣列晶片及一溫度控制器。 本方法可以用於偵測任何由細胞,細胞器,病毒,分子 及其聚合物或複合物所構成之群組所選取出來的成分之間 的交互作用。舉例來說,本方法可以用於偵測微分子,例 士口 DNA-DNA ’ DNA-RNA ,RNA-RNA,DNA-蛋白質, RNA -蛋白質及蛋白質-蛋白質等之間的交互作用。本方 法亦可用於偵測微分子-小分子或小分子-小分子之交互作 用。本方法亦可用於偵測包括兩個成分以上之間的交互作 -24- 本紙張尺度適用中國國家標準(CNS) A4規格(210 X 297公釐) 1254744 A7 _B7 _ 五、發明説明(22 ) 用的更複雜的交互作用。當要偵測DNA-DNA,DNA-RNA ,RNA-RNA交互作用時,該接觸,換言之,雜交,步 驟,可以在適當的情況下,例如,在低,中或高嚴謹度下 實施。 該測試成分及該多個目標成分之間的交互作用可以利用 適當的方法進行偵測。舉例來說,可以將該測試成分及該 目標成分標示以促進偵測。可以使用任何適當的方法進行 標示。標示的範例包括放射性,螢光,化學,酵素,冷光 以及FRET (螢光共振能量轉換)標示。該冷光標示可以係 化學發光標示或生物體發光標示。該標示可以直接或間接 地,獨自地附著或結合至測試成分,獨自地附著或結合至 目標成分,或附著或結合至兩者。所讀出的結果可以係正 或負信號。可以使用任何適當的化驗方式,包括三明治式 或競爭法方式。 在較佳的具體實例中,本方法係用以偵測介於測試成 分及多個基因,基因片段或它們的編碼產物之間的交互作 用。更佳的係,多種目標基因,基因片段或它們的編碼產 物都包含在生物路徑中,屬於具有完全相同或相似生物功 月匕之蛋白i群組’表現相同的細胞周期階段,表現相同的 細胞型態,表現相同的組織型態,表現相同的器官型態, 表現相同的開發階段,蛋白質的表現以及/或是活動會在 不健康或無秩序型態或階段的時候發生改變,或蛋白質之 表現以及/或是活動可以利用藥品或其它的處理予以改 變。 -25- 本紙張尺度適用中國國家標準(CNS) A4規格(210 X 297公釐) 1254744 A7 —_B7__ 五、發明説明(23 ) 本方法可用以偵測單一測試成分或物質及多個目標成分 之間的交互作用。較佳的係,本方法係使用於高總流量的 模式下,換言之,用以偵測多個目標成分或物質及多個目 標成分之間的交互作用。介於測試成分或物質及多個目標 成分之間的交互作用可以同時或連續性地偵測。 D·範例裝置說明 圖1所示的係範例積體微陣列裝置之俯視圖式。該裝置 包括基底1。基底1係由塑膠,玻璃,碎,陶瓷等所製造 並且可以渗透或不可滲透,剛體或可弯曲。 可以利用適當的方法,例如蝕刻,在基底1上製造多個 反應井2。接著在每個反應井中放入微陣列晶片3 ^反應 井的數量及不同井之間的距離可以根據實際需要進行修 正。建議井之參數(例如反應井的數量或不同井之間的距 離)與標準盤相同,例如標準96-井盤,384-井盤或1536-井 盤,以助於利用機器人進行自動化操作(例如樣本處理或 清洗)。在圖1所示的實例中,微陣列裝置的維度參數與 標準96-井盤相同。也就是說,在基底1上面有96個反應 井2,以及從某個井至鄭近井之間的距離係9 mm,與標準 96-井盤之鄰近井間的距離相同。 圖2所示的係微陣列裝置之井單元的三維圖式,其中會 顯示的係反應井2及附著的微陣列晶片3。反應井頂端部 的形狀係正方形的。其周圍尺寸應該小於或等於標準9 6 _ 井jut 放置在反應井2中的微陣列晶片3的形狀亦是正方 形的。在此較佳的具體實例中,反應井2及微陣列晶片3 •26- 本紙張尺度適财® ®家標準(CNS) A4規格(21GX 297公釐) '·~·'— - 1254744 A7 B7 五、發明説明(24 ) 的正方形形狀會確保微陣列晶片3的方向定位正確。熟習 的技術人員將會了解該形狀並非一定限制成正方形。其它 的形狀例如圓形也可用以形成反應井2及微陣列晶片3。 對微陣列晶片3而言,固定探針的表面係面朝上(圖2 A )或 面朝下(圖2 B )。反應井2的底部係密封以及試劑(例如, 雜交試劑或清洗試劑)可以從頂端(圖2 A)加入或是移除。 另外,該裝置的底端可設計成部份開放式的,也就是至少 一在該底部會製造一微流通道以便從底部(圖2 B )將試劑 (雜交試劑或清洗試劑)加入或是移除。反應井2係當作一 整體的裝置進行製造,或其包括至少兩個拆解的部份。舉 例來說,如果需要的話,可以拉下反應井的底部以便進行 後面的偵測。反應井2的深度可以根據微陣列晶片3的厚 度作修改而該反應容積則可以從數百微米改變至數公分。 當將本微陣列裝置用於偵測生物或製藥樣本時,可以將 探針可以根據它們的特性例如探針的根基數量或序列劃分 成不同的群組。接著可以將來自相同群組的探針固定在反 應井2的相同微陣列晶片3上。探針可以係cDNA,寡核:y: 酸’抗原或抗體,感覺器官,多肽,細胞或組織。微陣列 晶片3之基底可以係矽,玻璃或尼龍膜等。固定探針的方 法可以係吸收,共價結合,截留等(Beattie等人所著之 Molecular Biotechnology ,4:213-225, (1995);以及DESCRIPTION OF THE INVENTION 20 'idose s galactose, tal (5) 〇se) and fructose such as sedoheptulose Se (Sed〇heptul〇Se). Any lipid can be attached to the microarray wafer. Examples of genus include dimercaptoglycerols such as tristearyl sulphate, trisodium sulphate and triolein, stone walls, phosphoric acid: oils such as phospholipids, ethanolamine, phospholipid choline, phospholipid lysine, quercetin And cardiolipin, sphingolipids such as sphingomyelin, cerebral palsy and nerve sputum, sterols such as cholesterol and sterols and sterol fatty acid esters. Fatty acid Y is a saturated fatty acid such as lauric acid, stem acid, hexadecanoic acid, stearic acid, probiotic acid and perylenetetracarboxylic acid, or unsaturated fatty acid such as oleic acid, oil, linoleic acid, peanut acid. In a specific embodiment of the feature, at least two microarray wafers are attached to the island. However, any number or percentage of microarray wafers, for example, 50% microarray wafers, can be attached to multiple components. Preferably, each microarray wafer is attached to a plurality of components. The microarray wafer can be attached to the same type or different types of components. In another specific embodiment, at least one of the micro-locations includes a temperature controller. However, there may be any number or percentage of micro-positions, for example, 50% micro-positions, including temperature controllers. Preferably, each micro position includes a temperature controller. More preferably, each micro position includes a microarray wafer and a temperature controller. Some temperature controllers, such as 50% temperature controllers, can be individually controlled. Preferably, each temperature controller can be individually controlled. Any suitable temperature controller can be used in the device. For example, 'Resistive heaters can be used, bidirectional semiconductor temperature controller, Tao L__-23- This paper scale applies to China National Standard (CNS) A4 specification (210 X 297 mm) 1254744 A7 ---- B7 V. DESCRIPTION OF THE INVENTION (21) Porcelain heater or infrared heater. The substrate in the device can be a single unit. Alternatively, the substrate can be a modular unit that can be disassembled into at least two portions. C. Detection Method In another aspect, the present invention provides a method for detecting an interaction between a test component and various target components, the method comprising: & providing an integrated microarray device, The device includes a substrate having a plurality of individual micro-locations and a plurality of microarray wafers, wherein the number of micro-locations is equal to or greater than the number of micro-array wafers, and a plurality of target components are attached to the micro-array wafer; b) utilizing The plurality of target components provided in step a) are in contact with a test component; and c) detecting an interaction between the test component and the plurality of target components. The method can be used in any suitable category including prognosis, diagnosis, drug screening, environmental monitoring, and the like. Any suitable integrated microarray device, including those discussed in Section B above, can be used in the method. In a particular embodiment, the integrated microarray device includes a substrate having a plurality of individual micro-locations, each of which includes a microarray wafer and a temperature controller. The method can be used to detect any interaction between components selected by a group of cells, organelles, viruses, molecules, and their polymers or complexes. For example, the method can be used to detect interactions between micromolecules, such as DNA-DNA' DNA-RNA, RNA-RNA, DNA-protein, RNA-protein and protein-protein. This method can also be used to detect the interaction of micromolecules - small molecules or small molecules - small molecules. This method can also be used to detect the interaction between two components and above. -24 This paper scale applies to China National Standard (CNS) A4 specification (210 X 297 mm) 1254744 A7 _B7 _ V. Invention description (22) More complex interactions are used. When DNA-DNA, DNA-RNA, and RNA-RNA interactions are to be detected, the contacts, in other words, hybridization, steps can be carried out under appropriate conditions, for example, at low, medium or high stringency. The interaction between the test component and the plurality of target components can be detected using an appropriate method. For example, the test component and the target component can be labeled to facilitate detection. It can be labeled using any suitable method. Examples of indications include radioactivity, fluorescence, chemistry, enzymes, luminescence, and FRET (Fluorescence Resonance Energy Conversion) labeling. The luminescent indicator can be a chemiluminescent label or a bioluminescent label. The label may be attached or bound to the test component either directly or indirectly, attached or bound to the target component by itself, or attached or bonded to both. The result read can be a positive or negative signal. Any suitable assay can be used, including sandwich or competition. In a preferred embodiment, the method is used to detect interaction between a test component and a plurality of genes, gene segments or their encoded products. More preferably, a plurality of target genes, gene fragments or their encoded products are contained in the biological pathway, and belong to the same period of the cell cycle of the protein i group having the same or similar biological function. Type, performance of the same tissue type, performance of the same organ type, performance of the same development stage, protein performance and / or activity will change in an unhealthy or disorderly pattern or stage, or protein performance and / Or the activity can be changed with drugs or other treatments. -25- This paper size applies to Chinese National Standard (CNS) A4 specification (210 X 297 mm) 1254744 A7 —_B7__ V. Description of invention (23) This method can be used to detect a single test component or substance and multiple target components. Interaction between the two. Preferably, the method is used in a high total flow mode, in other words, to detect interaction between a plurality of target components or substances and a plurality of target components. The interaction between the test component or substance and the plurality of target components can be detected simultaneously or continuously. D. Example Device Description A top view of a typical integrated microarray device shown in FIG. The device comprises a substrate 1. The substrate 1 is made of plastic, glass, pulverized, ceramic, etc. and is permeable or impermeable, rigid or bendable. A plurality of reaction wells 2 can be fabricated on the substrate 1 by a suitable method such as etching. Then, the number of microwell wafers in each reaction well and the distance between different wells can be corrected according to actual needs. It is recommended that the parameters of the well (such as the number of reaction wells or the distance between different wells) be the same as standard plates, such as standard 96-well plates, 384-well plates or 1536-well plates, to facilitate automated operation with robots (eg Sample processing or cleaning). In the example shown in Figure 1, the dimensional parameters of the microarray device are the same as for the standard 96-well plate. That is, there are 96 reaction wells 2 on the substrate 1 and a distance of 9 mm from a well to Zheng near well, the same distance from the adjacent wells of the standard 96-well plate. Fig. 2 is a three-dimensional diagram of a well unit of a microarray device in which a reaction well 2 and an attached microarray wafer 3 are shown. The shape of the top end of the reaction well is square. The size around it should be less than or equal to the standard 9 6 _ well jut The shape of the microarray wafer 3 placed in the reaction well 2 is also square. In this preferred embodiment, the reaction well 2 and the microarray wafer 3 • 26 - the paper size of the standard ® ® standard (CNS) A4 specification (21GX 297 mm) '·~·' - - 1254744 A7 B7 5. The square shape of the invention (24) will ensure that the orientation of the microarray wafer 3 is correctly positioned. A skilled artisan will appreciate that the shape is not necessarily limited to a square. Other shapes such as a circular shape may also be used to form the reaction well 2 and the microarray wafer 3. For the microarray wafer 3, the surface of the fixed probe is face up (Fig. 2A) or face down (Fig. 2B). The bottom of the reaction well 2 is sealed and reagents (eg, hybridization reagents or cleaning reagents) can be added or removed from the top (Fig. 2A). In addition, the bottom end of the device can be designed to be partially open, that is, at least one microfluidic channel can be fabricated at the bottom to add or remove reagents (hybridization reagents or cleaning reagents) from the bottom (Fig. 2B). except. The reaction well 2 is manufactured as a unitary device or it comprises at least two disassembled parts. For example, if necessary, the bottom of the reaction well can be pulled down for later detection. The depth of the reaction well 2 can be modified depending on the thickness of the microarray wafer 3, and the reaction volume can be changed from several hundred micrometers to several centimeters. When the present microarray device is used to detect biological or pharmaceutical samples, the probes can be divided into different groups based on their characteristics, such as the number or sequence of probes. Probes from the same group can then be immobilized on the same microarray wafer 3 of the reaction well 2. The probe may be a cDNA, oligocore: y: acid' antigen or antibody, sensory organ, polypeptide, cell or tissue. The substrate of the microarray wafer 3 may be a crucible, a glass or nylon film or the like. The method of immobilizing the probe may be absorption, covalent binding, retention, etc. (Beattie et al., Molecular Biotechnology, 4: 213-225, (1995);

Subramanian等人所著之Enzyme &⑷⑽化丨丁—⑽, 21:26-34,(1999))。 在許多的例子中,例如診斷一種疾病,篩選一種藥品或 _____ - 27 - 本紙張尺度適用巾a g家標準(CNS) A4規格(210 X 297公釐了 1254744 A7Enzyme & (4) (10) by Subramanian et al. (10), 21:26-34, (1999)). In many cases, such as diagnosing a disease, screening a drug or _____ - 27 - this paper scale applies to the towel a g home standard (CNS) A4 specification (210 X 297 mm 1254744 A7

研究某些特定基因功能,並非一定需要高密度的微 本裝置之微陣列晶片3係低密度的微陣列晶片,於其上口 有數十或數百個固定的探針。低密度微陣列可以降低許; 對應的製造成本。纟另_方面,本發明之微陣列裝置 多個單元(舉例來說’單元數量為96,3 8 4或1536 )。:炊 每個反應㈣探針數量Μ,但是全㈣妓應井加起^ 的探針數量則有數千至數萬個可以達到高產量分析 提供中等的密度。 為了控制每個反應井2的溫度,如圖2所示,會將溫产 控=器6附著至每個反應井2上。圖3所示的係不同溫= 制器6之間的連接範 <列。每個溫度控帝】器6分別有兩條直 線9及9’分別連接至電源供應器的陽極及陰極。不同反應 井2的溫度個別控制係利用不同溫度控制器6的可定址啟 動/關閉來達成。 溫度控制器6可以就是一個電阻以替反應井2加熱。其 可以附著至反應井2的底部。如果基底係由矽製造的話, 便可以利用微製造技術以蝕刻反應井2的相反面,接著在 矽上沉積一金屬(例如銅)層在矽上以製造溫度控制器6。 亚且反應井2的底部可以製造得愈薄愈好以有助於溫度控 制器6及反應井2中微陣列晶片3之間的熱傳導。另外,溫 度控制器6可以係雙向半導體溫度控制器。在某一方面, 該雙向半導體溫度控制器會加熱反應井2 •在另一方面, 當其溫度係高於環境溫度(例如5〇〇c )時其會冷反應井2。 此雙向的半導體溫度控制器可以附著至反應井2的底部α -28- 本紙張尺度適用中國國家標準(CNS) Α4規格(210X297公釐)To study certain specific gene functions, it is not necessary to have a high-density micro-device microarray wafer 3 low-density microarray wafer with dozens or hundreds of fixed probes on its upper mouth. Low-density microarrays can reduce the cost of manufacturing; Further, the microarray device of the present invention has a plurality of units (for example, the number of units is 96, 3 8 4 or 1536). :炊 The number of probes per reaction (4) is Μ, but the number of probes in the whole (four) 妓 well should be thousands to tens of thousands to achieve high yield analysis to provide medium density. In order to control the temperature of each reaction well 2, as shown in Fig. 2, a temperature control = 6 is attached to each reaction well 2. The connection temperature between the different temperatures = controller 6 shown in Fig. 3 is a column. Each of the temperature control devices 6 has two wires 9 and 9' respectively connected to the anode and cathode of the power supply. The individual temperature control of the different reaction wells 2 is achieved by addressable start/stop of different temperature controllers 6. The temperature controller 6 can be a resistor to heat the reaction well 2. It can be attached to the bottom of the reaction well 2. If the substrate is made of tantalum, microfabrication techniques can be utilized to etch the opposite side of the reaction well 2, followed by depositing a layer of metal (e.g., copper) on the crucible to fabricate the temperature controller 6. The bottom of the reaction well 2 can be made thinner as possible to facilitate heat transfer between the temperature controller 6 and the microarray wafer 3 in the reaction well 2. Alternatively, the temperature controller 6 can be a bidirectional semiconductor temperature controller. In one aspect, the bi-directional semiconductor temperature controller heats the reaction well 2 • On the other hand, it cools the reaction well 2 when its temperature is above ambient temperature (e.g., 5 〇〇 c). This bidirectional semiconductor temperature controller can be attached to the bottom of the reaction well 2 α -28- This paper scale applies to the Chinese National Standard (CNS) Α 4 specification (210X297 mm)

1254744 A7 _______B7 五、發明説明(26 ) 溫度控制器6亦可以利用圖2B的方法放進反應井2中。溫 度控制器6可以利用機械嵌接的方式結合至微陣列晶片 3。另外,茲結合可以利用引入一層液體以達成,該液體 反應期間並不會參與反應或蒸發。該結合力量係介於此液 體(表面及溫度控制器6表面之間的表面張力。此外,所 引入的液體有助於熱傳導。 熟習本技藝人士將會了解任何種類的溫度控制器,非限 制於電阻器或雙向半導體溫度控制器,都可以應用於本發 明足溫度控制器6中。舉例來說,陶瓷加熱器可以藉由將 其直接附著於反應井2之底部而應用於溫度控制器6。另 外’紅外線加熱器可以利用非接觸的紅外線光波加以應 用。介於溫度控制器6及電腦之間的連接方法以達成溫度 控制器6之定址控制並非侷限於上面所提及的方法。任何 適當的溫度控制方法都可以使用。 在圖1及圖2所示的本發明裝置之較佳具體實例中,透 過母個反應井之間的絕緣踏上所製造的洞口( hole ),便可 以利用薄薄的橫樑將不同反應井互相連接有助於不同反應 井2之間的熱絕緣。如果系統的強度足夠的話,該洞口的 大小應該越大越好。舉例來說,如果該基底係由塑膠製 造,每個細孔的大小係3 X 2公釐。根據所使用的材料的不 同’會利用不同的製造方法,例如電射消融(Simpson等人 所著,Proc· Natl. Acad· Sci. USA,21:2256-2261 (1998)), 铸造法(Becker 等人所著,Sensors Update, 2:208-238 (1998) :以及 Delamarche 等人所著,J. Am. Chem. Soc.,120:500- ____-29- 本紙張尺度適用中國國家標準(CNS) A4規格(210 X 297公釐) 1254744 A7 __ B7 五、發明説明(27~) 508 (1998)),以及浮雕法(κ〇ρρ等人所著,Current Opinion in Chemical Biology,丄:410-419 (1997))。 當將本微陣列裝置應用於生化反應時,在將溶液加入反 應井2的微陣列晶片3之後便會利用覆蓋條(cover_slip )以 覆蓋樣本溶液。其將可以避免樣本的蒸發。以及根據微陣 列晶片的大小(小於微陣列晶片3之區域)該覆蓋條的大小 係可伸縮的。另外,如圖2所示,高沸點厭水有機試劑 (例如礦油)可用於限制該反應系統。該試劑量的容積係由 樣本容積及微陣列晶片的區域決定。 如圖2 B所示,當將微陣列晶片3以面朝下的方式放置在 反應井中時,可以加入厭水及生物相容液體1 〇以填滿反 應井2。並且此液體的重力及沸點應該比水還高以使樣本 漂浮在該液體上方以與附著在微陣列晶片3之探針交互作 用。在反應之後,可以經由反應井2底部所製造的微流通 道抽出液體1 0,並且可以將清洗溶液加入。 該反應偵測的結果可以利用電量搞合裝置(CCD )或同位 素影像器加以完成。其應該在將標示方法應用於樣本時便 已經決定。積體微陣列裝置可以放置顯微鏡上,其可以以 預設的距離穩定地移動。該偵測器一次可以偵測一個微陣 列晶片3,接著可以機動地移動至下一個要掃描的反應井 的位置。此類偵測裝置相當的便宜,有效率,簡單並且易 於使用,所以可以將它們應用在小型醫院或實驗室中。 引用的春者文獻:1254744 A7 _______B7 V. DESCRIPTION OF THE INVENTION (26) The temperature controller 6 can also be placed in the reaction well 2 using the method of Figure 2B. The temperature controller 6 can be coupled to the microarray wafer 3 by mechanical inlay. Alternatively, the combination can be achieved by introducing a layer of liquid that does not participate in the reaction or evaporation during the reaction. The bonding force is between the surface tension of the liquid (the surface and the surface of the temperature controller 6. In addition, the introduced liquid contributes to heat conduction. Those skilled in the art will be aware of any type of temperature controller, not limited to A resistor or a bidirectional semiconductor temperature controller can be applied to the foot temperature controller 6 of the present invention. For example, the ceramic heater can be applied to the temperature controller 6 by attaching it directly to the bottom of the reaction well 2. In addition, the 'infrared heater can be applied by using non-contact infrared light waves. The connection method between the temperature controller 6 and the computer to achieve the address control of the temperature controller 6 is not limited to the above-mentioned method. Any suitable The temperature control method can be used. In the preferred embodiment of the apparatus of the present invention shown in Figs. 1 and 2, the hole formed by the insulation between the mother reaction wells can be thinned. The beams interconnect the different reaction wells to facilitate thermal insulation between the different reaction wells 2. If the strength of the system is sufficient, the holes are The larger the size, the better. For example, if the substrate is made of plastic, the size of each pore is 3 x 2 mm. Depending on the materials used, different manufacturing methods, such as electro-absorption, can be used. (Simpson et al., Proc. Natl. Acad. Sci. USA, 21: 2256-2261 (1998)), Casting Method (Becker et al., Sensors Update, 2: 208-238 (1998): and Delamarche J. Am. Chem. Soc., 120:500- ____-29- This paper scale applies to China National Standard (CNS) A4 specification (210 X 297 mm) 1254744 A7 __ B7 V. Description of invention ( 27~) 508 (1998)), and embossing method (〇κρρ et al., Current Opinion in Chemical Biology, 丄: 410-419 (1997)). When applying the microarray device to biochemical reactions, After the solution is added to the microarray wafer 3 of the reaction well 2, a cover strip (cover_slip) is used to cover the sample solution. This will avoid evaporation of the sample. And depending on the size of the microarray wafer (less than the area of the microarray wafer 3) The size of the cover strip is scalable. In addition, as shown in Figure 2, the height is high. A boiling point hydrophobic organic reagent (such as mineral oil) can be used to limit the reaction system. The volume of the reagent is determined by the sample volume and the area of the microarray wafer. As shown in Figure 2B, when the microarray wafer 3 is facing When placed in the reaction well, a hydrophobic and biocompatible liquid can be added to fill the reaction well 2. The gravity and boiling point of the liquid should be higher than water to allow the sample to float above the liquid for attachment. Probe interactions on the microarray wafer 3. After the reaction, the liquid 10 can be withdrawn through the microchannel manufactured at the bottom of the reaction well 2, and the cleaning solution can be added. The result of the reaction detection can be accomplished using a power-distribution device (CCD) or an isotope imager. It should have been decided when applying the labeling method to the sample. The integrated microarray device can be placed on a microscope that can be stably moved at a preset distance. The detector can detect one microarray wafer 3 at a time and can then be moved to the position of the next reaction well to be scanned. Such detection devices are relatively inexpensive, efficient, simple and easy to use, so they can be used in small hospitals or laboratories. Quoted Springs literature:

Beattie W.G·等人所著之”Hybirdization of DNA targets to -30- 本紙張尺度適用中國國家標準(CNS) A4規格(210 X 297公董)"~ ---- 1254744 A7 B7 五、發明説明(28 ) glass-tethered oligonucleotide probesM, Moleuclar Biotechnology 4: 213-225 , 1995Beattie WG· et al. "Hybirdization of DNA targets to -30- This paper scale applies to China National Standard (CNS) A4 specification (210 X 297 dong) "~ ---- 1254744 A7 B7 V. Invention Description (28) glass-tethered oligonucleotide probesM, Moleuclar Biotechnology 4: 213-225 , 1995

Becker H.等人戶斤著之 ’’Integrated capillary electrophoresis for chemical analysis1',於 Baltes H.等人所著,Sensors Update,Vol.3, VCH Weiheim 208-238,1998 Delamarche E. 等人所著之 ’’Microfluidic networks for chemical patterning of substrate: Design and application to bioassays”,J. Am. Chem. Soc. 120: 500_508,1998 Fodor S.P. A. 等人所著之,’Light-directed spatially addressable parallel chemical synthesis”,Science 251: 767-773, 1991''Integrated capillary electrophoresis for chemical analysis1' by Becker H. et al., by Baltes H. et al., Sensors Update, Vol. 3, VCH Weiheim 208-238, 1998 by Delamarche E. ''Microfluidic networks for chemical patterning of substrate: Design and application to bioassays", J. Am. Chem. Soc. 120: 500_508, 1998 by Fodor SPA et al., 'Light-directed spatially addressable parallel chemical synthesis', Science 251: 767-773, 1991

Hacia J.G.等人所著之”Detection of heterozygous mutations in BRCA1 using high density oligonucleotide arrays and two-colour fluorescence analysis”,Nature Genetics 14: 441-447, 1996 ;"Detection of heterozygous mutations in BRCA1 using high density oligonucleotide arrays and two-colour fluorescence analysis" by Hacia J.G. et al., Nature Genetics 14: 441-447, 1996;

Heller R.A.等人所著之”Discovery and analysis of inflammatory disease-related genes using cDNA microarrays", Proc. Natl. Acad. Sci. USA 94: 2150-2155, 1997 Kopp M.U.等人戶斤著之"Developments in technology and applications of microsystems”,Current Opinion in Chemical Biology 1: 410-419,1997,Heller RA et al. "Discovery and analysis of inflammatory disease-related genes using cDNA microarrays", Proc. Natl. Acad. Sci. USA 94: 2150-2155, 1997 Kopp MU et al. "Developments in Technology and applications of microsystems", Current Opinion in Chemical Biology 1: 410-419, 1997,

Simpson P.C.等人所著之 ’’High_throughput genetic analysis using microfabricated 96-sample capillary array electrophoresis microplates",Proc. Natl. Acad. Sci. USA 95: _____-31 -_ 本紙張尺度適用中國國家標準(CNS) A4規格(210 x 297公釐) 1254744 A7 B7 五、發明説明(29 ) 2256-2261, 1998Simpson PC et al. ''High_throughput genetic analysis using microfabricated 96-sample capillary array electrophoresis microplates", Proc. Natl. Acad. Sci. USA 95: _____-31 -_ This paper scale applies to Chinese National Standard (CNS) A4 Specifications (210 x 297 mm) 1254744 A7 B7 V. Description of invention (29) 2256-2261, 1998

Subramanian A.等人戶斤著之 ’’Comparison of techniques for enzyme immobilization on silicon supports”, Enzyme & Microbial Technol.24: 26-34,1999。 上面的實例只是作為解釋用途而非希望限制本發明之範 疇。可以對上述的部份進行許多的變化。因為熟習本技藝 人士將會了解上述實例的修改及變化,因此本發明只受限 於隨附之申請專利範圍。 _-32- 本紙張尺度適用中國國家標準(CNS) A4規格(210 X 297公釐)Subamanian A. et al. ''Comparison of techniques for enzyme immobilization on silicon supports', Enzyme & Microbial Technol. 24: 26-34, 1999. The above examples are for illustrative purposes only and are not intended to limit the invention. Various changes may be made to the above-mentioned parts. As those skilled in the art will understand the modifications and variations of the above examples, the present invention is limited only by the scope of the attached patent application. _-32- This paper scale applies China National Standard (CNS) A4 specification (210 X 297 mm)

Claims (1)

I254f _〇〇〇23號專利申請案 中文申請專纖圍替換本(94年10月) ?件(。月::糊修(更乂 中产牟44^ 公告采 1. 2. 3. 一種積體微陣列梦~ J 扁置,该I置包括具有多個個別微位4 以及多個微陣列曰ΰ从甘产 ^ 又仅置 j日日片的基底,其中該微位置的數量等於 ^ ^ ^ J日日片的數i,且其中該等微位置係包含 禝數個井之并执4 1 h ^ s σ式,/、中王部的井係藉由利用薄橫摔連 接之内及外牆所定義, /、知運 一和 我/、τ /專秩樑及井之内及外牆形成 =^間,以包含惰性氣體及對彼此相鄰之井進行熱絕 :申請專利範圍第4之裝置,其中該基底包括矽,塑 膠,玻璃,陶瓷,橡膠,聚合物或其組合。 ,申請專利範圍第2項之裝置’其中該㈣、:氧化石夕或 氮化>5夕。 4·如申請專利範圍第!項之裝置’其中該基底包括厭水或 親水之表面。 5·如申請專利範圍第1IM之裝置,其中該基底包括多孔性 或無孔性之表面。 6·如申請專利範圍第!項之裝置,其中該微位置及/或微陣 列晶片係在該基底上製造。 7·如申請專利範圍第丨項之裝置,其包括(12)11個微位置, 其中η係至少為1之整數。 8·如申請專利範圍第丨項之裝置,其中該微位置係平均地 或不平均地分配在該基底中。 9 ·如申請專利範圍第1項之裝置,其中該微位置之數量及 微位置之間的距離符合標準微滴定盤。 1〇·如申請專利範圍第1項之裝置,其包括(12)η個井,其中η 1254744I254f _〇〇〇23 Patent Application Chinese Application Specialized Fiber Replacing (94 October) ? (. Month:: Paste Repair (More 乂中中牟44^ Announcement 1. 2. 3. An integrated body) The microarray dream ~ J flat, the I set includes a substrate having a plurality of individual micro-bits 4 and a plurality of micro-arrays, and the number of the micro-positions is equal to ^ ^ ^ The number i of the J-day film, and wherein the micro-locations contain a number of wells and hold 4 1 h ^ s σ, /, the middle part of the well is connected by using thin and thin The definition of the wall, /, Zhiyun I and I /, τ / special rank beam and the formation of the inside and outside of the well = to contain inert gas and heat the adjacent wells: patent application scope 4 The device, wherein the substrate comprises ruthenium, plastic, glass, ceramic, rubber, polymer or a combination thereof. The device of claim 2, wherein the (four),: oxidized stone or nitriding > · The device of claim 2, wherein the substrate comprises a surface that is hydrophobic or hydrophilic. 5. If the device of the patent application range is 1IM Wherein the substrate comprises a porous or non-porous surface. 6. The device of claim 2, wherein the micro-location and/or microarray wafer is fabricated on the substrate. A device comprising: (12) 11 micro-positions, wherein η is at least an integer of 1. 8. The device of claim 3, wherein the micro-location is evenly or unevenly distributed 9. In the apparatus of claim 1, wherein the number of the micro-positions and the distance between the micro-positions conform to the standard microtiter plate. 1) The device of claim 1 of the patent scope includes ( 12) n wells, where η 1254744 六、申請專利範圍 係至少為1之整數。11·如申請專利範圍第i 個井。 、之I置,其包括96,384或1,536 12. 如申睛專利範圍第1項 橢圓形,正方形,、之褒置,其中該井具有從圓形’ 組成之群組中裡私 形’三角形以及其它不規則形狀所13. 如申請專利範圍第::的幾何形狀。 同的形狀。 、之裝置,其中該井具有相同或 M.如申請專利範圍第丨 以流體方式與流體=衣置,其中至少一個微位置 15·如申請專利範圍第丨或該裝置外部之流體通道接觸 流體方式與流體來源^裝置’其中全部的微位置係 他如申請專利範圍第^裳置外部之流體通道接觸。 係以流體方式互相接觸之裝置’其中至少有兩個微位 Π·如申請專利範圍第1項之裝置 流體方式互相接觸。 、 18·如申請專利範圍第丨項之裝置 氣。 ’ 19.如申請專利範圍第1項之裝置, 微陣列晶片。 t 2〇.如申請專利範圍第1項之裝置, 相同或不同的密度。 21·如申請專利範圍第1項之裝置,其令該微陣列晶片具 (100)n sp〇t/Cm2之密度,其中n係至少為!之整數 /、 不 係 以 置 其中全部的微位置係 以 ,其中該惰性氣體係空 其中每個微位置包括一 其中該微陣列晶片具 有 有 2- 本紙張尺度適财關家料(CNS) Α4·(21()χ297公着) A8 B8 C8 1254744 申請專利範圍 22·如申睛專利範圍第1項之裝置,其中至少一項微陣列晶 片具有小於或等於400 sp〇t/cm2之密度。 23·如申凊專利範圍第1項之裝置,其中全部的微陣列晶片 具有小於或等於400 sp〇t/cm2之密度。 24·如申凊專利範圍第1項之裝置,其中至少有—個微陣列 晶片會附著多個成分。 25·如申凊專利範圍第2 4項之裝置,其中該微陣列晶片係以 面朝上或面朝下的方向附著多個成分。 26·如申請專利範圍第2 4項之裝置,其中每個成分係從由細 胞’細胞器,病毒,分子及其聚合物或複合物所組成之 群組中選取出來的。 27·如申請專利範圍第2 6項之裝置,其中該細胞係從由動物 細胞’植物細胞,細菌細胞,重組細胞以及人工培養細 胞所組成之群組中選取出來的。 28·如申請專利範圍第2 6項之裝置,其中該細胞器係從由細 胞,線粒體,葉綠粒,核糖體,ER,高爾基體,溶酶 體,蛋白酶體,分泌水泡,液泡及微粒體所組成之群組 中選取出來的。 29. 如申請專利範圍第26項之裝置,其中該分子係由無機分 子,有機分子以及其複合物所組成之群組中選取出來 的。 30. 如申請專利範圍第29項之裝置,其中該無機分子係從由 鈉,鉀,鎂,鈣,氯,鐵,銅,鋅,錳,鈷,碘,鉬, 飢’鎳’銘’氟’碎,錫,硼以及坤離子所組成之群組 -3- 本紙張尺度適用中國國家標準(CNS) A4規格(210X 297公釐)6. The scope of application for patents is at least an integer of 1. 11. If the patent application is the i-th well. I, which includes 96, 384 or 1,536 12. For example, the elliptical, square, and arbitrage of the first item of the scope of the patent, wherein the well has a private shape from a group consisting of a circle' 'Triangles and other irregular shapes. 13. As claimed in the patent scope:: geometry. The same shape. And the apparatus wherein the well has the same or M. as in the scope of the patent application, fluidly and fluid=suited, wherein at least one micro-position 15 is in contact with the fluid passage of the fluid passage outside the apparatus or the external passage of the apparatus All of the micro-locations of the fluid source device are in contact with the fluid channel outside the patent application. A device that is in fluid contact with each other' wherein at least two of the micro-positions are in fluid contact with each other as in the first aspect of the patent application. 18) For example, the device gas of the scope of the patent application is applied. 19. A device as claimed in claim 1, microarray wafer. t 2〇. The same or different density as the device of claim 1 of the patent application. 21. The apparatus of claim 1, wherein the microarray wafer has a density of (100) n sp〇t/Cm2, wherein n is at least! The integer/, is not tied to all of the micro-positions, wherein the inert gas system is empty, wherein each micro-position includes one in which the micro-array wafer has a 2-paper scale suitable for home (CNS) Α 4 A device of the first aspect of the invention, wherein at least one of the microarray wafers has a density of less than or equal to 400 sp〇t/cm 2 . 23. The device of claim 1, wherein all of the microarray wafers have a density of less than or equal to 400 sp〇t/cm2. 24. The device of claim 1, wherein at least one of the microarray wafers has a plurality of components attached thereto. The device of claim 24, wherein the microarray wafer has a plurality of components attached in a face-up or face-down direction. 26. The device of claim 24, wherein each component is selected from the group consisting of a cell organelle, a virus, a molecule, and a polymer or complex thereof. 27. The device of claim 26, wherein the cell line is selected from the group consisting of animal cells, plant cells, bacterial cells, recombinant cells, and artificial culture cells. 28. The device of claim 26, wherein the organelle is derived from cells, mitochondria, chloroplasts, ribosomes, ER, Golgi, lysosomes, proteasomes, secretory vesicles, vacuoles and microsomes Selected from the group consisting of. 29. The device of claim 26, wherein the molecule is selected from the group consisting of inorganic molecules, organic molecules, and complexes thereof. 30. The device of claim 29, wherein the inorganic molecule is derived from sodium, potassium, magnesium, calcium, chlorine, iron, copper, zinc, manganese, cobalt, iodine, molybdenum, hunger 'nickel' 'Group of broken, tin, boron and Kun ion -3- This paper scale applies to China National Standard (CNS) A4 specification (210X 297 mm) 裝 春 六、申請專利範圍 中選取出來的。 31. 如申請專利範圍第29項之裝置,其中 胺基酸,肽,I 6所从# 巧风刀于係攸由 貝,乜甘酸,寡核苷酸,核酸,維生 =早㈣’寡醣,碳水化合物,脂質及其複合物所祖 成之群組中選取出來的。 32. =料利範圍第1項之裝置,其中至少有兩個微陣列 日日片附著至多個成分上。 33. 如:請專利範圍第32項之裝置,其中每個微陣列晶片會 附者至相同型式或不同型式之成分。 34. 如申請專利範圍第」項之裝置,其中每 經附著至多個成分。 3 ^ 其中至少有一個微位置 其中每個微位置都包括 其中每個溫度控制器係 其中該溫度控制器係從 35·如申請專利範圍第1項之裝置 包括一溫度控制器。 36·如申请專利範圍第3 5項之裝置 一溫度控制器。 37·如申請專利範圍第3 5項之裝置 可個別地控制。 38·如申凊專利範圍第3 5項之裂置 由私阻式加熱器,雙向半導體溫度控制器,陶竟加妖哭 或紅外線加熱器所組成之群組中選取出來的。 39·如申請專利範圍第1項之裝置,其中該基底係單一單 元。 40.如申請專利範圍第!項之裝置,其中該基底係組合單 元’其可以拆解成至少兩個部份。 -4 - 本紙張尺度適用中國國家標準(CNS) A4規格(210 X 297公釐) 1254744Installed in the spring six, the scope of the patent application. 31. The device of claim 29, wherein the amino acid, the peptide, the I 6 is from the #巧风刀于系攸, 乜, 乜, 寡, 寡, oligonucleotide, nucleic acid, vitamin = early (four) 'olig Selected from the group of sugars, carbohydrates, lipids and their complexes. 32. = Device of claim 1, wherein at least two of the microarray day sheets are attached to a plurality of components. 33. For example, please refer to the device of Article 32 of the patent, in which each microarray wafer is attached to the same type or different types of components. 34. The device of claim 1, wherein each of the devices is attached to a plurality of components. 3 ^ wherein there is at least one micro-position, wherein each of the micro-positions includes each of the temperature controllers, wherein the temperature controller is from the apparatus of the first aspect of the invention, including a temperature controller. 36. As for the device of claim 35, a temperature controller. 37. The device of claim 35 can be controlled individually. 38. For example, the cracking of the third paragraph of the patent scope is determined by a private resistance heater, a bidirectional semiconductor temperature controller, a group consisting of a ceramic crying or an infrared heater. 39. The device of claim 1, wherein the substrate is a single unit. 40. If you apply for a patent scope! The device of the item, wherein the substrate unit is 'disassembled into at least two parts. -4 - This paper size is applicable to China National Standard (CNS) A4 specification (210 X 297 mm) 1254744 、申請專利範圍 上•戈α曱 氣體 42. -種 方法 a) 別微 數量 該微 數個 之内 間, b) 成分 範圍第1項之裝置’其包含複數個含有惰性 工間,且該複數個空間係均勻地分佈。 用二偵測測試成分及多個目標成分間之交互作用之 ’該方法包括: 提種積體微陣列裝置,該裂置包括具有多個個 =及多個微陣列晶片的基底,其中該微位置的 :於,該微陣列晶片的數量,以及多個附著至 列3曰片之目標成分’且其中該等微位置係包含複 之井格式,其中全部的井係藉由利用薄橫標連接 及外牆所定義’其中薄橫樑及井之内及牆形成一空 乂包δ b性氣體及對彼此相鄰之井進行埶絕緣. 利用步驟a)所提供之該多個目標成分接觸一測試 ;以及 c)❹】該測試成分及多㈣標成分之間的交互作用。 •如申請專利範圍第42項之方法,其中該積體微陣列裳置 ^括3有夕個個別微位置的基底而每個微位置都包括一 微陣列晶片及一溫度控制器。 44·如申請專利範圍第42項之方法’其中要進行偵測的交互 作用係從由細胞’細胞器,病毒,分子及其聚合物或複 合物所組成之群組中選取出來的成分之間的交互作用。 枚如申請專利範圍第42項之方法,其中該多個目標成分係 多個基因,基因片段或其編碼產物。 46·如申明專利範圍第4 5項之方法,其中該多個基因,基因 片段或其編碼產物係包含於生物路徑,屬於具有相同或 -5- 1254744, the scope of the patent application • Ge α曱 gas 42. - a method a) other micro-number of the inside, b) the scope of the device of the first item 'which contains a plurality of inert chambers, and the plural The space is evenly distributed. Using two to detect the interaction between the test component and the plurality of target components, the method comprises: extracting an integrated microarray device, the split comprising a substrate having a plurality of = and a plurality of microarray wafers, wherein the micro Position: the number of the microarray wafers, and a plurality of target components attached to the column 3' and wherein the micro-locations comprise a complex well format, wherein all wells are connected by using a thin cross-mark and The outer wall defines 'where the thin beam and the inner wall of the well and the wall form an empty δ b gas and the adjacent wells are insulated. The plurality of target components provided in step a) are contacted with a test; c) ❹ The interaction between the test component and the multiple (four) standard components. • The method of claim 42, wherein the integrated microarray is provided with a substrate having an individual micro-position and each micro-position includes a microarray wafer and a temperature controller. 44. The method of claim 42 wherein the interaction to be detected is between components selected from the group consisting of a cell organelle, a virus, a molecule, and a polymer or complex thereof. Interaction. The method of claim 42, wherein the plurality of target components are a plurality of genes, a gene fragment or an encoded product thereof. 46. The method of claim 45, wherein the plurality of genes, gene fragments or encoded products thereof are contained in a biological pathway and belong to the same or -5-1254744 相似生物功能之蛋白質群組,表現在相同的細胞周期階 段’表現相同的細胞型態,表現相同的組織型態,表現 同的g型恶,表現相同的開發階段,蛋白質的表現 以及/或是活動會在不健康或無秩序型態或階段的時候 發生改變,或蛋白質之表現以及/或是活動可以利用藥 品或其它的處理予以改變。 47·如申明專利範圍第4 2項之方法,其中會偵測多個目標成 为及多個目標成分之間的交互作用。 48.如申請專利範圍第4 2項之方法,其中會同時或連續地偵 測多個目標成分及多個目標成分之間的交互作用。 -6 - 本紙張尺度適用中國國家標準(CNS) A4規格(210 X 297公釐)A group of proteins with similar biological functions, which behave in the same cell cycle stage, exhibiting the same cell type, exhibiting the same tissue type, exhibiting the same g-type evil, showing the same developmental stage, protein expression and/or Activities may change in an unhealthy or disorderly manner or stage, or protein performance and/or activity may be altered using drugs or other treatments. 47. The method of claim 4, wherein the interaction between the plurality of targets and the plurality of target components is detected. 48. The method of claim 4, wherein the interaction between the plurality of target components and the plurality of target components is detected simultaneously or continuously. -6 - This paper size applies to Chinese National Standard (CNS) A4 specification (210 X 297 mm)
TW91100023A 2002-01-03 2002-01-03 Integrated microarray devices TWI254744B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
TW91100023A TWI254744B (en) 2002-01-03 2002-01-03 Integrated microarray devices

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TW91100023A TWI254744B (en) 2002-01-03 2002-01-03 Integrated microarray devices

Publications (1)

Publication Number Publication Date
TWI254744B true TWI254744B (en) 2006-05-11

Family

ID=37607497

Family Applications (1)

Application Number Title Priority Date Filing Date
TW91100023A TWI254744B (en) 2002-01-03 2002-01-03 Integrated microarray devices

Country Status (1)

Country Link
TW (1) TWI254744B (en)

Similar Documents

Publication Publication Date Title
JP3650615B2 (en) Integrated microarray device
JP4179876B2 (en) Clinically intelligent diagnostic apparatus and method
Vermesh et al. High-density, multiplexed patterning of cells at single-cell resolution for tissue engineering and other applications
US7901886B2 (en) Microfluidic extraction method
US20030228637A1 (en) Novel microarrays and methods of use thereof
US8293519B2 (en) Microarray devices having controllable reaction volume
Ahmed et al. Advancements and potential applications of microfluidic approaches—a review
CN1280428C (en) Biochip system based on minute particle and its application
Valles et al. Maskless Photochemical Printing of Multiplexed Glycan Microarrays for High-Throughput Binding Studies
JP4230460B2 (en) Microarray device with controllable reaction volume
US20030143722A1 (en) Four dimensional biochip design for high throughput applications and methods of using the four dimensional biochip
TWI254744B (en) Integrated microarray devices
AU2001280003B2 (en) Integrated microarray devices
AU2001280003A1 (en) Integrated microarray devices
JP5087898B2 (en) Analysis chip
JP2010014669A (en) Analysis chip
US20100256012A1 (en) Flexible extraction method for the production of sequence-specific molecule libraries
Menzel EDDS, an Escherichia coli-based system with a variety applications amenable to miniaturization
Metspalu et al. Universal and flexible DNA microarray approach: arrayed primer extension

Legal Events

Date Code Title Description
MM4A Annulment or lapse of patent due to non-payment of fees